rfhg_36146.1

Basic information about the TSS

---

TSS ID: rfhg_36146.1 Species: human Chr: chr2		Start: 181901887 End: 181902182 Strand: +
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK091197:0 GeneID: 6744 HGNC/MGI_ID: HGNC:11319 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ITPRID2 Gene_symbol: ITPRID2 Gene_synonyms: CS-1 KIAA1927 KRAP SPAG13 Gene_source: HGNC:11319

TATA-Box annotation

---

Distance to TSS:	10304
Nearest PromoterID:	NM_001130445
Entrez ID:	6744
Nearest Unigene:	Hs.196983
Nearest Refseq:	NM_006751
Nearest Ensembl:	ENSG00000138434
Gene Name:	ITPRID2
Gene Alias:	CS-1|CS1|KRAP|SPAG13|SSFA2
Gene Type:	protein-coding
CpG%:	0.013559
GC%:	0.368243
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ITPRID2 p2@ITPRID2 p3@ITPRID2 p4@ITPRID2 p5@ITPRID2 p6@ITPRID2 p7@ITPRID2 p8@ITPRID2 p9@ITPRID2 p10@ITPRID2
Sample		p1@ITPRID2	p2@ITPRID2	p3@ITPRID2	p4@ITPRID2	p5@ITPRID2	p6@ITPRID2	p7@ITPRID2	p8@ITPRID2	p9@ITPRID2	p10@ITPRID2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.82	1.75	1.36	4.48	2.34	5.45	0.39	0.78	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.47	5.06	2.23	4.25	3.84	4.25	1.21	0.20	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.75	1.54	1.54	3.47	3.28	1.93	1.16	0.58	1.16	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.57	3.12	1.04	4.78	2.49	2.70	1.25	0.62	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.72	3.37	2.25	4.50	3.60	2.70	0.00	0.45	1.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.59	3.10	2.13	5.23	2.91	2.13	0.78	1.16	1.16	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.66	2.40	1.31	1.53	3.05	2.18	0.00	0.00	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.54	1.21	0.24	2.66	1.21	2.66	0.24	0.24	0.73	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.98	1.92	0.85	1.71	2.14	1.71	0.64	0.64	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	4.06	0.58	6.38	2.90	2.32	0.58	0.58	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	7.68	1.21	1.62	3.23	4.85	3.64	0.40	0.81	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.29	5.69	0.00	5.29	3.25	3.25	0.41	1.22	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	21.44	2.10	2.42	1.77	0.48	0.81	0.16	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.79	1.65	1.20	0.90	0.60	1.95	0.15	0.45	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.34	2.20	2.63	2.85	0.66	0.88	0.22	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.08	1.01	1.26	1.76	0.00	1.51	0.50	0.75	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	18.56	0.44	2.18	1.09	0.22	1.97	0.00	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.61	2.11	1.69	1.27	1.27	2.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	2.67	1.07	1.60	1.07	1.60	0.00	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.40	1.50	1.65	1.81	0.45	0.60	0.00	0.30	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.16	1.34	1.60	1.74	0.80	0.67	0.00	0.27	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.46	1.73	0.86	1.04	0.86	1.73	0.86	0.35	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.57	1.29	1.68	0.90	0.26	1.29	0.00	0.26	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.29	0.49	2.67	1.46	0.24	0.97	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.64	1.55	1.03	1.55	0.52	0.77	0.00	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.88	2.53	0.32	1.27	0.63	0.63	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	1.10	1.65	0.55	0.00	2.20	0.55	0.00	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	0.24	2.59	2.12	0.94	1.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.56	1.13	1.62	0.65	0.32	0.97	0.00	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.50	1.27	0.54	0.90	0.54	0.90	0.18	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.86	1.67	0.84	0.84	0.00	0.63	0.21	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.01	0.39	0.98	1.17	1.37	0.20	0.00	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	0.42	1.06	1.06	0.21	0.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	7.75	1.48	1.65	0.49	0.33	0.99	0.00	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	1.68	1.50	0.56	0.75	0.93	0.19	0.00	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.77	1.34	1.92	1.72	0.38	1.53	0.38	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.36	1.02	1.23	0.41	0.00	1.02	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	0.60	2.62	1.21	0.60	1.01	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	0.81	1.89	0.81	0.27	0.81	0.27	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	3.84	1.20	0.72	2.16	0.48	0.96	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.00	0.71	1.41	1.18	0.24	1.18	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.12	1.02	1.32	0.88	0.29	0.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.96	1.27	0.63	2.53	0.42	1.05	0.42	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.64	1.22	2.27	2.10	0.17	1.40	0.35	0.17	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	7.03	1.20	1.81	1.20	0.40	1.81	0.00	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.14	1.16	1.16	1.40	0.23	0.47	0.70	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.12	1.68	1.92	2.64	0.24	0.96	0.24	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.75	1.49	2.09	1.49	0.30	0.89	0.30	0.30	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.49	1.20	1.20	2.63	0.48	1.20	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.92	1.01	1.82	0.81	0.20	1.82	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.02	0.61	0.82	2.66	0.41	1.64	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.78	0.00	1.11	1.78	0.00	1.11	0.00	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	0.00	1.06	1.42	0.00	2.13	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	4.64	0.66	1.33	2.32	0.00	1.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	1.68	0.84	0.84	1.68	1.68	0.00	1.68	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.30	0.46	0.46	0.46	0.00	1.38	0.92	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.81	0.00	0.97	2.27	0.65	1.62	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.99	0.32	0.64	0.96	0.00	1.28	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	6.29	0.31	1.26	0.94	0.31	0.31	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	1.41	0.71	2.12	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	0.00	2.24	0.00	0.00	1.12	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.96	0.80	3.18	3.98	0.00	0.80	0.00	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.12	0.34	1.36	1.02	0.68	1.02	0.34	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.37	0.97	1.30	1.30	0.32	2.92	0.00	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	0.35	1.06	2.13	0.35	0.71	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	16.16	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	0.00	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	0.98	1.46	1.95	0.00	0.49	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	0.99	3.47	0.50	0.50	1.98	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	1.41	0.00	2.35	0.00	1.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	0.33	1.99	1.66	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.83	0.93	1.55	0.93	0.00	1.55	0.00	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.23	0.61	1.83	3.06	0.00	2.14	0.00	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	14.73	1.11	2.53	1.43	3.01	0.79	0.00	0.63	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	11.55	1.28	1.44	0.96	1.76	0.96	0.16	0.96	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	15.27	3.18	2.04	0.89	3.31	0.38	0.25	0.51	0.64	0.00
Adipocyte - omental, donor2	11474-119C7	11.96	0.00	4.48	1.49	0.75	1.49	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	10.72	0.67	0.67	1.34	1.34	0.67	0.00	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	9.57	0.64	0.00	1.28	0.64	1.91	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	0.90	0.90	0.45	0.45	1.81	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.87	0.17	0.87	0.52	0.17	0.35	0.00	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	22.10	1.17	0.98	1.56	0.39	0.98	0.20	0.59	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	10.81	0.26	0.51	0.77	0.77	0.77	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	10.04	1.12	1.12	0.84	0.28	0.56	0.00	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	17.05	1.18	1.76	0.59	0.00	0.59	0.59	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	30.40	1.21	1.37	0.72	0.72	0.72	0.40	0.56	0.16	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	19.04	0.65	1.94	0.97	1.61	0.65	0.00	0.32	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	0.53	1.60	0.53	0.53	1.07	0.00	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	0.00	0.56	1.67	2.23	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	15.39	0.42	0.83	0.83	1.25	0.42	0.83	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	11.80	0.50	0.75	0.25	0.25	0.25	0.50	0.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	0.98	0.33	0.98	0.65	0.65	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	0.00	1.52	0.30	0.61	0.00	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.64	2.43	1.77	1.10	0.88	0.66	0.00	0.44	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	0.36	0.72	2.15	0.00	0.72	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.96	3.60	0.72	1.26	4.32	2.16	3.60	2.52	0.18	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	3.35	0.00	3.35	3.35	0.00	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	24.04	2.47	1.23	0.82	5.14	2.67	3.29	1.03	0.41	1.64
Anulus Pulposus Cell, donor1	11248-116E6	19.34	3.55	1.95	1.72	1.03	0.23	0.69	0.23	0.80	0.57
Anulus Pulposus Cell, donor2	11463-119B5	13.96	0.98	2.45	1.22	0.49	0.73	0.73	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	2.25	0.90	0.00	2.25	4.04	2.25	1.80	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.44	2.60	1.30	0.00	2.60	2.17	1.74	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	2.14	2.14	6.42	0.00	0.00	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.04	3.59	2.39	2.09	4.48	0.90	0.90	0.60	1.20	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	3.79	0.00	0.00	3.79	2.53	2.53	0.00	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	0.66	1.32	0.66	1.32	0.66	0.66	1.32	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.12	1.95	1.62	0.97	2.92	1.62	1.62	1.62	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.82	3.88	1.46	1.46	6.80	0.49	2.91	0.97	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	2.38	0.59	1.78	2.97	0.00	0.59	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.21	2.64	2.64	1.51	4.14	1.51	2.64	1.13	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	5.08	2.18	2.90	5.81	2.18	0.73	2.18	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	5.02	1.25	0.00	2.51	0.00	2.51	2.51	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	5.11	2.97	0.99	4.28	1.32	1.81	2.80	0.49	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	1.36	0.00	0.00	4.09	2.73	2.73	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.48	3.17	2.11	1.96	4.07	1.51	0.75	0.75	0.00	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	4.29	1.61	0.00	4.29	0.54	4.29	1.07	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.05	6.05	2.46	0.94	3.21	2.08	1.89	0.94	0.19	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.11	4.28	2.41	1.60	3.74	0.53	1.07	1.07	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	3.90	0.98	0.00	2.93	0.98	3.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.38	3.32	1.99	1.66	4.64	1.33	2.49	0.83	0.33	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	3.60	0.00	1.20	0.00	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	3.54	0.00	3.54	0.00	0.00	7.08	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.13	4.12	3.09	2.06	2.57	1.03	3.26	2.06	0.51	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00	8.39	0.00	4.19	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	1.94	1.46	1.46	4.85	1.46	2.91	2.43	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	1.90	2.66	0.38	7.21	1.52	3.42	2.66	0.76	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	3.63	0.00	1.21	2.42	2.42	3.63	2.42	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	22.23	2.28	3.42	1.71	8.55	1.14	1.14	1.14	1.14	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.86	2.35	1.71	1.07	4.70	1.92	3.63	2.14	0.21	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.58	2.58	1.29	1.03	3.36	1.29	1.55	1.55	1.03	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	1.41	1.88	0.47	2.82	1.88	2.35	2.35	2.35	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.76	2.89	1.29	1.61	3.22	2.57	1.61	0.96	0.64	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	28.54	4.28	1.43	0.71	4.28	2.14	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	21.06	2.92	1.75	1.17	8.77	1.75	1.75	1.17	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.88	2.11	1.20	1.51	3.91	1.51	3.31	0.90	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	1.19	0.00	1.19	4.75	1.19	1.19	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.85	3.05	1.02	1.02	5.09	0.51	2.03	0.51	0.51	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	26.74	3.06	1.78	1.53	5.09	2.04	2.55	1.78	0.51	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	4.45	2.54	0.64	1.27	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	1.29	1.29	1.73	9.06	1.73	3.88	1.73	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.80	4.23	2.75	1.48	5.08	1.27	2.12	2.54	0.85	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.14	2.61	1.45	0.58	2.03	1.74	2.32	0.58	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	19.84	4.72	0.94	1.89	5.67	1.89	0.94	1.89	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.11	3.22	2.54	1.19	4.75	2.03	3.56	1.19	0.34	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	4.63	2.32	0.00	0.00	4.63	2.32	4.63	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	2.11	0.00	0.00	6.34	2.11	4.23	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.30	3.65	3.00	2.36	3.65	1.72	2.57	1.07	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	0.60	0.60	0.00	3.61	0.60	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	2.92	2.92	0.73	1.46	2.19	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.46	2.76	2.30	0.69	2.99	0.46	2.07	0.92	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	7.65	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	21.86	1.53	2.03	0.76	3.31	0.76	0.00	1.53	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.02	2.27	1.65	1.45	2.89	1.45	0.41	0.41	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.75	1.84	0.92	0.61	2.14	1.53	0.31	1.53	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.77	1.43	1.91	1.43	4.30	1.91	3.82	0.96	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	16.63	1.55	2.22	1.55	2.22	0.22	1.33	1.33	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	1.53	1.53	1.53	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	1.11	1.11	1.11	2.22	3.32	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	3.44	1.32	1.06	1.85	2.12	1.06	0.79	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.45	0.00	1.82	1.82	1.45	0.36	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	6.63	1.35	2.09	2.21	0.61	2.21	0.86	0.25	0.37	0.37
Astrocyte - cerebellum, donor2	11580-120F5	12.32	1.20	1.20	2.91	0.68	2.23	0.86	0.00	0.34	0.86
Astrocyte - cerebellum, donor3	11661-122F5	3.15	0.63	0.21	1.68	0.00	0.84	0.21	0.00	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	34.86	9.41	6.27	4.18	3.83	2.79	2.44	0.35	1.74	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	34.30	9.54	5.18	6.63	3.07	6.96	4.53	0.97	2.26	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	27.59	5.52	4.33	5.97	1.04	4.03	2.68	0.89	0.60	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	6.19	0.92	3.10	3.44	0.00	3.10	0.11	0.00	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	6.01	1.00	3.38	3.76	0.25	3.01	0.25	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.58	0.68	2.28	2.62	0.00	3.76	0.11	0.11	0.00	0.23
Basophils, donor1	12241-129G9	23.54	10.46	11.25	3.66	2.35	6.02	0.26	1.57	1.31	0.52
Basophils, donor2	12242-129H1	20.93	6.49	9.38	2.53	2.89	4.33	1.08	2.16	1.80	0.36
Basophils, donor3	12243-129H2	44.69	8.08	5.73	3.82	6.17	4.70	1.62	1.47	2.20	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	6.47	0.22	0.86	0.65	0.43	0.22	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.00	0.46	0.46	0.00	0.91	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	9.41	0.63	0.63	1.26	0.00	1.26	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	10.19	1.04	1.25	1.25	0.21	2.08	0.83	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.60	1.38	0.69	1.61	0.23	1.15	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.78	1.26	3.42	2.34	0.90	1.08	0.00	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	2.06	0.62	1.44	1.13	0.10	0.72	0.00	0.10	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.59	1.16	2.10	3.49	0.00	2.10	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.02	6.40	6.08	1.92	0.64	4.16	0.64	1.28	1.92	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	66.50	12.40	8.45	4.51	5.64	1.69	3.94	3.38	5.64	0.56
CD14+ Monocytes, donor2	11305-117B9	47.33	10.95	10.39	3.90	6.12	6.50	1.67	2.78	2.23	0.56
CD14+ Monocytes, donor3	11381-118B4	40.39	12.29	7.68	3.29	5.05	6.37	0.66	1.54	3.95	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.99	2.26	2.55	1.42	1.13	0.00	0.28	0.85	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.46	3.03	1.14	0.76	1.52	1.14	0.00	0.76	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	40.44	2.63	2.96	1.64	2.30	3.94	0.99	1.31	1.97	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	45.68	6.50	4.91	2.46	4.34	4.19	0.43	2.02	1.59	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	35.91	6.03	3.62	5.43	9.66	6.03	0.60	4.22	3.62	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	63.72	11.84	4.26	4.97	10.66	5.45	3.08	6.16	2.61	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.14	8.37	4.35	3.35	4.35	4.02	0.33	2.18	1.67	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.36	12.70	5.24	3.31	8.28	6.35	0.55	4.42	3.86	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	24.54	6.69	5.70	3.72	8.68	4.71	0.50	4.46	5.21	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	30.54	7.24	2.74	2.74	4.11	3.52	0.20	1.96	2.35	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.56	7.30	4.10	3.56	9.08	3.92	0.53	3.56	3.03	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.78	8.49	5.22	5.01	10.66	5.22	2.18	6.31	3.70	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	23.41	8.43	4.45	2.58	3.75	4.45	0.70	2.34	2.58	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	28.51	10.03	2.11	4.22	10.56	4.75	0.53	3.70	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	29.95	6.66	6.66	3.33	7.77	2.22	0.00	6.66	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.50	9.67	5.80	4.16	4.76	4.76	0.30	2.23	2.38	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	31.73	7.78	4.99	3.39	8.38	4.19	1.80	3.39	3.19	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	41.85	8.33	5.00	2.29	12.91	4.16	1.25	5.20	2.91	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	35.46	14.64	6.86	3.89	8.92	5.49	1.14	2.97	5.26	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	28.50	11.99	5.66	3.62	14.25	5.88	1.36	6.33	3.17	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.68	4.80	3.49	3.49	10.04	4.36	0.44	3.93	4.36	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	40.62	8.34	6.46	4.57	8.34	2.96	0.27	3.50	4.30	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	39.78	13.61	4.54	4.54	8.03	5.23	1.05	5.76	4.01	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	43.34	15.57	8.84	4.63	10.94	5.05	1.26	8.42	5.89	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.01	15.43	6.43	2.39	4.96	4.96	1.29	2.02	3.12	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	29.59	8.81	3.87	6.34	10.22	4.23	1.76	6.34	4.23	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	32.03	6.14	5.70	4.83	6.58	5.26	0.44	2.63	2.63	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.46	8.20	5.06	2.62	5.41	4.71	0.52	2.62	2.79	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	27.50	8.92	5.20	2.23	8.55	5.20	1.12	2.60	3.35	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	35.78	9.70	5.17	2.80	13.15	4.10	1.29	6.04	3.45	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	26.21	11.88	3.28	2.87	7.37	3.28	0.00	0.82	4.09	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.56	7.88	2.78	3.25	11.36	3.71	0.23	4.17	3.71	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	34.33	10.67	3.94	4.41	15.08	4.41	1.62	4.41	3.25	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	23.32	4.14	1.96	2.18	2.62	1.09	0.22	1.74	1.09	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	30.49	4.16	3.00	2.31	2.54	1.85	0.92	3.23	2.54	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	25.99	3.03	1.95	1.73	3.47	2.60	0.43	2.17	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	44.69	4.83	4.67	2.18	2.49	1.71	0.16	1.09	1.56	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	37.37	4.89	4.72	2.27	3.14	1.75	0.70	1.75	1.05	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	51.51	4.46	3.57	3.57	3.12	3.34	0.89	3.12	1.78	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	26.79	4.08	3.32	3.32	2.04	2.55	0.26	0.77	0.00	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	34.91	3.51	3.51	2.63	5.05	2.20	0.66	1.76	2.42	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	26.74	1.68	3.37	4.42	2.95	2.53	0.42	1.68	1.47	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	6.10	6.10	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1.36	0.68	5.42	2.71	0.00	2.71	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	0.00	4.14	2.07	0.00	4.14	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	5.33	2.13	2.67	2.13	0.00	2.13	0.00	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.22	1.07	3.22	0.00	0.00	4.82	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.11	1.40	2.81	2.11	0.00	3.51	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	1.57	3.92	3.14	0.00	5.49	0.00	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	1.32	1.32	5.27	0.00	2.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	1.64	0.82	3.29	5.75	0.82	13.97	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	4.35	0.00	2.90	7.98	0.73	7.98	0.73	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.50	0.00	5.05	7.57	0.00	8.08	0.00	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.06	3.23	4.44	4.04	0.40	0.81	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.99	0.40	3.60	4.39	0.80	1.20	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	23.09	12.05	4.02	4.02	2.01	5.02	4.02	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	19.66	4.49	7.87	3.37	5.62	10.11	3.37	1.12	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.19	4.88	3.01	2.25	0.75	3.38	0.38	1.88	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.25	2.93	2.71	2.48	2.71	2.25	0.90	0.90	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	2.14	1.79	9.28	5.71	0.00	9.28	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.22	1.22	4.90	5.51	0.61	6.12	0.00	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	1.52	1.22	5.49	3.96	0.30	3.96	0.00	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.06	0.51	2.81	2.55	0.00	1.79	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.94	0.00	6.29	2.92	0.22	2.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	2.59	0.57	3.74	4.31	0.29	4.60	0.00	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	0.00	8.06	6.64	1.42	0.47	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	0.00	6.32	4.92	0.00	2.81	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	3.30	0.00	3.30	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	3.61	1.01	5.93	3.61	0.43	2.31	0.14	0.14	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.91	0.85	6.10	3.90	0.17	4.07	0.00	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.55	1.13	4.84	5.80	0.32	2.58	0.00	0.16	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.90	3.59	2.69	0.00	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.05	0.70	6.99	3.84	0.00	4.54	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.44	4.40	3.96	0.00	4.84	0.44	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	0.84	3.79	2.53	0.00	2.53	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	5.61	1.45	3.12	2.70	0.00	2.29	0.00	0.21	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4.68	0.00	3.68	3.01	0.67	3.34	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.82	1.09	9.52	8.16	0.00	7.07	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	0.00	8.58	8.58	1.07	7.50	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	0.00	1.79	7.17	0.00	3.59	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	5.01	0.93	6.12	3.71	0.19	2.78	0.00	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.98	0.65	4.12	4.77	0.00	2.60	0.00	0.00	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2.10	1.89	4.83	5.25	0.00	2.94	0.00	0.21	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.01	1.52	2.53	1.52	0.00	2.02	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	0.43	6.07	2.17	0.00	0.87	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.87	0.87	2.61	1.74	0.44	3.05	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	2.47	1.48	7.92	4.95	0.00	2.47	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	0.92	6.46	4.62	0.00	1.85	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	5.58	6.98	0.00	6.98	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	7.48	0.83	4.43	4.98	0.55	3.32	0.00	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2.70	0.98	5.15	5.64	0.00	4.17	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3.08	0.00	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	5.73	0.72	6.45	6.09	0.00	4.30	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	2.77	5.54	0.00	5.54	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1.96	0.98	9.17	5.89	0.33	6.88	0.00	0.00	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	0.38	1.13	9.39	5.26	0.00	3.75	0.00	0.38	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	1.26	3.03	8.84	3.28	0.00	5.81	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.63	2.52	2.75	3.44	2.52	2.75	1.15	2.29	0.23	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.98	2.88	2.40	2.88	5.03	1.20	0.96	2.16	0.24	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	10.67	2.74	0.82	1.37	3.56	1.09	0.00	1.37	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.61	5.70	3.60	0.90	2.40	1.80	1.20	4.20	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	10.08	2.88	2.16	2.40	4.32	0.96	2.16	3.12	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.69	3.64	3.18	2.27	3.41	1.36	0.91	1.82	0.45	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.78	1.52	0.87	2.61	3.04	2.61	1.09	2.17	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.26	2.11	1.58	1.84	1.32	2.37	0.79	1.84	1.32	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	9.38	2.58	1.88	2.35	3.75	1.64	1.17	1.88	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.19	3.92	3.62	1.81	4.83	1.21	1.21	2.72	0.91	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.65	2.32	2.32	1.16	2.32	2.91	1.45	2.61	0.87	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.33	3.46	1.33	4.00	4.53	1.07	2.13	1.87	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	3.94	1.75	3.06	1.75	2.19	3.50	5.69	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.76	3.64	1.82	2.73	2.73	2.73	2.73	2.28	1.37	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	3.73	1.49	1.49	3.73	2.24	2.24	2.24	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.52	3.60	4.68	1.44	4.32	3.24	2.16	2.52	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.36	4.32	2.59	3.16	3.45	1.73	0.86	2.01	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.02	3.30	2.83	1.89	2.59	2.36	0.71	1.65	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	14.58	1.58	0.63	1.27	6.02	3.80	4.12	2.54	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	2.46	1.54	3.08	3.38	1.85	1.23	3.38	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.34	3.21	2.56	2.56	4.17	1.60	0.64	2.56	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	11.47	4.59	1.91	2.68	3.82	1.53	1.91	2.29	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.46	3.55	1.18	2.36	4.34	1.97	1.58	2.36	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	4.54	0.00	2.27	4.54	1.51	2.27	1.51	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	4.82	4.01	7.23	4.01	5.62	1.61	0.80	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	4.90	5.60	4.20	3.50	7.69	2.80	2.10	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	5.01	4.01	6.01	8.01	4.01	4.01	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	29.24	3.66	3.66	9.14	3.66	0.00	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	9.88	0.99	0.99	0.49	1.48	0.49	0.99	2.96	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.00	2.10	1.37	0.63	0.42	1.47	0.53	0.21	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	27.04	2.77	4.51	2.77	3.47	1.04	2.08	2.43	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	8.17	1.42	2.49	2.49	2.13	1.42	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	29.92	7.17	5.69	2.84	5.23	2.84	1.93	1.48	0.80	1.14
Chondrocyte - re diff, donor2	11339-117F7	9.85	0.90	2.69	0.90	1.79	0.00	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.37	0.40	2.83	1.21	2.02	2.02	0.40	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	51.99	16.87	8.61	7.23	9.30	7.34	9.87	4.71	4.36	8.38
Ciliary Epithelial Cells, donor2	11323-117D9	44.04	12.40	7.91	5.13	5.99	5.77	5.77	3.21	1.50	7.48
Ciliary Epithelial Cells, donor3	11399-118D4	52.13	12.74	5.75	6.19	8.23	8.94	11.33	3.89	3.10	8.67
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	32.83	6.05	6.42	8.16	2.66	4.95	1.65	0.28	1.10	0.46
Corneal Epithelial Cells, donor1	11526-119I5	3.07	0.22	0.22	0.22	0.00	0.00	0.66	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	0.00	0.00	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.35	0.51	0.51	0.00	0.00	1.02	0.00	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.09	3.80	1.32	1.49	3.80	1.16	0.33	3.96	1.32	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.08	3.15	1.89	3.47	6.31	2.84	0.63	4.10	0.95	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45	0.00	0.00	0.00	3.45	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.28	1.73	1.19	1.73	2.81	1.51	0.54	2.38	0.65	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	17.08	4.44	7.86	1.71	0.68	6.15	0.00	0.68	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.79	3.26	9.14	2.61	1.96	6.53	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	2.90	10.65	4.36	0.97	9.19	0.00	0.48	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	37.69	3.17	1.33	0.50	2.84	1.83	3.50	0.83	0.67	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	11.74	1.76	0.59	0.00	0.00	2.35	3.52	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	27.43	1.13	1.70	0.57	2.83	0.85	3.11	1.13	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	31.45	1.57	0.39	0.79	1.97	0.79	2.75	0.79	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	11.63	0.29	0.87	0.00	1.45	0.29	1.16	0.29	0.29	0.58
Endothelial Cells - Artery, donor2	11341-117F9	21.65	2.82	0.24	0.24	2.12	1.41	3.29	0.94	0.24	0.94
Endothelial Cells - Artery, donor3	11413-118E9	20.51	2.10	0.70	0.70	2.28	1.05	1.75	0.70	0.53	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	55.19	3.55	1.77	1.33	3.32	4.88	5.76	2.22	0.44	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.77	5.17	3.04	2.43	7.30	2.74	8.52	0.61	0.91	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.29	7.33	3.38	1.41	3.38	4.23	3.95	1.97	1.13	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	16.34	0.59	0.89	0.59	1.49	1.19	2.08	0.59	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	1.56	1.04	0.52	0.52	1.56	1.04	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	17.44	1.84	0.71	0.57	0.57	1.28	2.13	0.57	0.28	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	41.61	1.60	1.20	0.80	8.80	4.80	6.40	2.40	0.80	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	0.52	0.52	0.00	2.10	2.10	1.05	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	73.18	5.96	3.98	1.86	6.46	5.59	3.85	2.48	0.87	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	71.91	5.00	1.52	4.13	3.69	4.78	3.69	1.09	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	95.02	5.74	4.15	3.42	4.64	6.72	6.35	1.34	0.85	1.47
Endothelial Cells - Vein, donor1	11267-116G7	28.44	0.00	1.14	0.00	0.00	1.14	4.55	1.14	1.14	2.28
Endothelial Cells - Vein, donor2	11344-117G3	27.94	4.19	0.70	0.00	1.40	0.70	6.99	0.00	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	53.54	3.14	1.10	1.26	4.40	3.93	10.05	1.41	0.31	2.51
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	77.56	23.10	19.80	4.95	13.20	21.45	3.30	1.65	4.95	0.00
Eosinophils, donor3	12246-129H5	49.94	10.70	14.27	7.13	0.00	7.13	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	0.49	0.49	0.98	0.00	0.24	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	0.00	0.00	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	1.23	1.23	1.64	0.82	2.05	0.82	1.23	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.82	1.31	1.09	0.88	0.88	0.99	0.55	0.55	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.53	1.73	1.73	2.49	0.87	1.08	0.33	0.43	0.43	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	23.65	4.00	2.18	2.06	3.40	1.82	1.94	0.85	0.49	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	21.84	5.19	4.23	1.23	3.55	1.09	2.18	0.68	1.50	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.24	2.74	1.37	1.16	1.58	1.79	0.42	0.21	0.63	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.13	1.32	1.05	0.53	1.84	1.32	1.84	0.79	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.25	2.66	4.65	3.65	2.66	2.99	0.66	0.66	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	9.07	2.72	0.91	1.36	3.18	1.36	0.91	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	3.03	2.27	1.52	0.00	1.52	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.04	1.89	1.73	0.32	1.26	1.10	0.47	0.16	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	38.80	4.85	4.85	0.61	4.85	2.73	2.12	0.91	0.00	2.73
Fibroblast - Cardiac, donor5	11456-119A7	33.12	2.54	2.54	1.78	3.68	1.40	2.41	1.02	0.38	0.76
Fibroblast - Cardiac, donor6	11460-119B2	31.08	3.18	2.88	2.43	3.18	3.18	3.79	1.52	0.15	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.07	1.21	0.94	0.94	1.47	1.47	1.34	0.27	0.54	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.69	2.16	1.29	0.86	2.16	0.43	1.73	0.43	0.43	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	7.32	4.39	1.46	1.46	1.46	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.30	1.15	0.92	0.69	0.92	0.69	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.60	1.02	2.71	0.34	0.17	1.02	0.51	0.34	0.34	0.51
Fibroblast - Dermal, donor1	11269-116G9	12.44	2.58	1.41	1.41	0.70	1.41	0.70	0.94	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	9.43	1.42	1.89	0.47	1.42	0.47	0.94	0.94	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	16.20	1.45	2.06	0.48	0.85	0.97	0.36	0.36	0.00	0.24
Fibroblast - Dermal, donor4	11450-119A1	19.56	1.36	3.17	3.73	0.90	3.28	0.23	0.34	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	19.71	1.57	1.92	1.22	0.35	1.22	0.70	0.35	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	17.05	2.44	2.44	2.92	0.00	1.62	0.16	0.00	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	43.10	3.12	3.33	1.25	6.25	2.08	1.46	1.46	1.25	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	79.65	9.96	5.76	3.41	18.60	5.50	7.34	3.93	2.36	3.14
Fibroblast - Gingival, donor2	11318-117D4	66.55	10.54	5.01	4.88	3.69	6.98	6.46	1.19	1.19	2.37
Fibroblast - Gingival, donor3	11394-118C8	35.87	2.61	2.13	0.77	2.32	1.84	0.48	0.29	0.48	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	81.03	11.43	4.16	2.08	22.86	1.04	12.47	6.23	1.04	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	30.31	4.76	2.11	1.23	3.00	1.76	2.64	1.06	0.35	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.99	6.08	4.21	2.65	6.08	2.18	2.81	1.25	1.09	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	66.80	5.54	3.65	1.62	6.22	2.43	4.06	2.16	1.49	2.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	49.40	3.53	1.76	2.82	2.82	1.06	2.12	0.35	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	38.32	3.22	2.78	2.19	1.90	0.88	1.17	1.17	0.73	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	38.86	3.41	2.45	1.23	3.27	1.23	1.91	2.05	0.27	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	39.93	2.85	3.07	2.19	2.63	1.54	0.33	1.54	1.10	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	41.67	4.11	2.79	2.05	4.70	1.17	1.47	0.44	0.59	0.59
Fibroblast - Lung, donor1	11270-116H1	9.52	1.36	0.00	1.36	4.08	1.36	4.08	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	11.94	7.46	2.98	14.92	5.97	5.97	8.95	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	36.51	8.65	3.17	2.32	4.43	4.22	4.85	0.42	0.84	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	0.83	1.67	0.00	0.00	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	0.00	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.84	0.28	0.28	0.56	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	18.27	3.25	2.44	2.44	1.62	2.44	0.41	0.00	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	47.52	7.18	4.85	4.07	4.07	3.69	3.10	0.39	1.75	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	60.67	12.13	9.10	8.04	3.49	7.74	5.46	1.52	1.67	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	68.54	6.12	6.12	3.06	10.40	2.14	4.59	0.92	1.22	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	26.71	3.82	4.58	2.29	0.76	4.20	2.29	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	15.39	1.89	1.89	1.08	1.62	1.62	0.00	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.78	3.83	2.09	1.97	3.36	2.32	2.32	0.81	0.46	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.45	2.32	1.77	1.44	2.65	1.11	0.88	0.66	0.22	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	45.92	5.89	4.88	3.25	4.67	3.66	10.97	1.83	2.24	4.27
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.68	0.67	0.00	0.67	0.00	2.00	0.00	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.84	0.40	1.58	0.00	0.00	1.19	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.20	4.96	4.17	2.98	4.17	2.38	2.98	1.19	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.94	2.49	3.02	1.07	1.95	1.24	0.53	0.00	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.63	2.56	2.56	1.97	0.79	0.99	0.00	0.59	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.75	1.20	2.11	1.50	1.81	1.20	0.30	0.30	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.62	2.05	2.81	1.94	1.73	1.40	0.97	0.54	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.28	2.53	2.78	1.52	3.29	0.51	2.28	0.51	0.51	1.52
Fibroblast - skin normal, donor1	11553-120C5	18.70	2.63	3.94	0.82	2.95	1.15	0.66	0.49	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	26.27	1.80	1.40	2.01	2.61	1.60	0.20	0.80	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	9.74	1.00	2.61	2.61	1.41	1.11	0.30	0.90	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.88	0.60	3.32	2.12	1.81	1.21	1.51	0.60	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.81	3.56	3.73	1.16	1.24	0.66	0.33	0.25	0.08	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.83	1.71	2.39	1.71	0.85	0.51	0.68	0.17	0.68	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.42	2.63	2.63	0.66	3.94	1.97	2.96	0.99	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	28.02	3.83	4.79	2.34	4.26	2.24	1.28	1.28	0.64	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	13.49	2.19	3.04	1.69	1.86	2.36	0.67	0.84	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.27	2.04	4.08	2.20	2.51	1.41	0.78	0.47	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	22.16	44.32	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	86.28	3.49	6.97	2.61	22.66	2.61	7.84	14.82	0.00	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.53	9.01	2.77	1.91	12.66	1.91	3.29	1.91	1.04	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	51.01	7.03	3.12	2.34	9.37	1.30	1.82	0.52	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.58	6.90	3.83	2.30	11.24	2.30	3.83	3.83	1.28	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.06	0.77	0.00	0.77	0.00	0.00	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	0.64	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	3.14	0.29	0.86	1.43	0.29	1.14	0.00	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.52	1.10	1.93	5.79	0.00	1.93	0.55	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.90	1.83	0.46	6.16	1.14	1.60	0.91	0.68	0.46	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	2.58	0.40	0.79	2.38	0.20	0.99	0.40	0.00	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.34	0.53	1.06	4.23	0.00	0.79	0.53	0.00	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.74	1.96	2.94	7.50	1.30	0.65	1.63	0.00	0.00	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	0.44	0.88	0.44	0.00	0.00	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.39	0.71	0.42	1.13	0.28	0.42	0.14	0.14	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	5.66	1.35	1.72	3.20	1.23	1.72	0.74	0.62	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	3.49	0.54	0.54	1.07	0.00	0.54	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	12.76	3.59	2.97	4.09	1.98	4.46	1.61	0.50	0.87	2.85
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8.44	1.80	1.25	3.05	0.55	1.94	0.69	0.14	1.11	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	6.71	0.20	0.61	0.20	0.81	1.02	0.81	0.20	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.15	4.79	1.60	2.05	3.42	3.42	4.11	0.00	0.68	4.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.84	1.62	1.62	2.74	1.25	2.12	1.00	0.25	0.37	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.33	1.97	0.66	1.09	1.31	1.31	1.31	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	20.09	2.66	1.48	5.02	1.48	5.02	2.07	0.00	0.89	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.97	1.59	2.07	4.61	0.95	2.70	0.95	0.64	0.32	2.54
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	10.50	1.56	0.45	2.01	1.34	1.79	1.79	0.45	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.92	3.63	2.02	2.42	1.01	4.23	1.61	0.00	0.20	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	11.87	2.88	2.04	4.75	1.02	3.22	1.19	0.51	0.68	1.70
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.21	3.72	1.86	1.86	2.39	2.13	2.22	0.71	0.53	2.13
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.95	4.06	2.71	4.68	0.62	2.71	2.60	0.42	0.83	1.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.71	3.24	2.22	3.24	0.68	2.39	2.39	0.34	0.68	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.26	1.77	1.77	6.20	0.89	3.43	1.33	0.55	0.22	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.88	2.41	2.91	2.33	2.75	2.66	2.00	0.58	0.67	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.21	3.88	1.63	4.29	3.47	4.08	3.47	1.02	0.82	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.85	1.86	2.89	4.95	1.03	2.48	2.06	0.83	0.62	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.33	2.88	2.08	6.23	1.04	2.88	0.69	0.58	0.58	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.85	2.00	2.67	3.67	1.83	1.50	2.00	0.33	0.33	2.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.96	1.76	1.10	3.53	0.66	1.32	0.66	0.22	0.22	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.08	1.23	1.60	3.81	0.98	3.81	2.09	0.37	0.37	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.94	3.24	2.43	2.76	1.13	2.27	1.78	0.65	0.65	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.60	3.53	1.60	6.41	0.96	3.21	2.89	0.64	0.32	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.30	2.18	1.99	3.13	1.61	3.22	1.23	0.28	0.38	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	19.77	1.90	2.06	3.32	1.74	2.06	0.95	0.47	0.63	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.98	1.22	2.13	3.04	1.52	1.52	1.52	0.00	1.82	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	16.52	2.93	2.20	4.18	1.05	2.61	1.67	0.63	0.42	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.59	0.88	0.88	2.85	1.10	1.54	1.76	0.22	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	2.52	1.12	4.49	1.12	2.81	1.40	0.28	1.96	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.59	2.22	1.02	1.85	1.20	2.22	1.39	0.28	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.16	2.14	1.60	1.87	0.80	0.80	0.27	0.27	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.96	1.38	1.53	1.68	2.14	2.30	1.99	0.46	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.08	1.42	1.30	1.55	1.81	1.17	0.78	0.13	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	2.71	2.17	1.90	0.81	1.90	0.54	1.36	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.88	3.32	0.92	2.03	0.74	0.74	0.92	0.37	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.33	2.63	0.88	2.63	0.44	2.41	0.22	0.22	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	32.73	2.98	2.98	0.99	0.99	0.99	5.95	0.00	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.61	2.51	2.24	1.58	1.32	2.24	1.06	0.92	0.26	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.00	3.43	1.21	1.41	1.01	1.41	0.40	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.84	7.12	4.32	3.56	2.29	4.07	2.29	0.25	1.02	2.54
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2.19	0.00	0.60	0.60	0.00	0.00	0.20	0.00	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	3.08	0.31	0.00	0.46	0.15	0.46	0.00	0.00	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.43	0.41	0.61	0.20	0.00	0.82	0.00	0.00	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.25	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.70	0.00	0.28	0.28	0.28	0.28	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1.38	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	2.47	0.00	2.47	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.09	0.77	0.77	2.32	0.39	1.16	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1.60	1.60	0.00	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	0.00	0.00	0.00	0.00	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.21	0.65	0.65	1.63	0.33	0.33	0.65	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	6.59	0.41	0.82	0.82	0.41	0.41	0.41	0.41	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.11	0.56	0.56	2.24	0.84	1.68	0.84	0.00	0.00	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.90	0.98	0.33	1.96	0.65	0.65	0.33	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.07	0.00	0.84	0.00	0.00	0.84	0.84	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.95	0.95	0.64	1.91	0.32	1.27	0.95	0.32	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	4.76	0.34	1.02	0.34	0.00	0.34	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	0.00	0.00	2.09	0.00	0.00	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	11.45	1.72	0.57	5.73	0.00	0.00	0.00	1.15	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.33	0.00	0.00	0.00	0.30	0.89	0.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	0.00	0.00	1.69	1.69	1.69	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	1.66	0.00	2.07	0.41	0.41	0.41	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	10.59	1.38	0.46	2.76	0.92	1.15	0.92	0.00	0.23	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	5.27	0.00	5.27	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.15	0.38	0.38	2.31	1.92	0.77	1.92	0.38	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.80	0.00	0.33	1.63	0.65	1.63	1.30	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	9.36	0.67	0.00	3.34	0.67	2.01	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.57	1.16	2.70	1.93	0.00	3.08	0.77	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.01	2.05	2.05	1.71	1.71	1.37	1.03	0.68	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	2.48	0.00	9.94	2.48	2.48	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.76	0.47	2.36	3.77	0.00	4.72	0.47	0.00	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	1.21	1.81	6.03	0.60	3.62	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.77	1.53	0.51	4.58	0.00	2.54	1.02	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.16	0.80	1.99	2.79	1.20	2.79	0.80	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	19.24	1.97	1.97	4.44	0.99	1.97	0.99	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	3.54	2.36	5.90	1.18	1.18	2.36	0.00	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.25	1.75	1.17	4.08	1.75	1.17	1.17	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	1.76	3.07	3.95	0.44	4.83	2.19	0.00	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	21.19	0.85	0.00	1.70	0.00	0.00	1.70	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	2.39	1.79	0.00	2.39	1.19	0.60	0.00	0.60	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	6.31	0.97	0.49	0.00	0.97	0.97	0.49	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	0.00	2.28	1.14	0.00	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.90	1.25	0.83	0.83	0.00	0.83	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	1.12	0.00	1.12	0.00	0.00	0.00	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.15	2.85	0.95	0.63	0.95	0.32	0.32	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.43	1.25	0.00	1.25	1.67	0.00	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	28.31	3.71	1.16	3.02	6.15	2.09	2.44	1.74	1.16	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.02	5.06	2.19	2.87	8.27	2.53	2.53	2.19	0.68	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.94	3.87	3.41	4.32	10.47	1.82	2.50	3.64	1.14	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	29.29	4.48	1.97	2.73	7.32	1.97	2.62	2.30	0.77	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	28.37	3.87	2.36	3.01	6.45	1.93	3.22	2.79	2.15	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	22.17	3.23	2.37	4.09	8.18	2.15	2.58	3.66	0.65	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.92	2.99	1.49	2.62	7.72	1.99	1.99	1.99	0.87	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.87	3.43	1.37	2.23	8.41	2.40	2.06	2.40	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.66	3.84	1.28	4.81	9.29	0.64	1.92	2.88	0.96	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	24.06	0.56	0.56	2.24	1.68	3.36	2.24	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.43	0.87	0.43	0.00	0.87	0.43	0.87	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	2.64	2.64	0.00	7.93	5.29	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.59	1.41	0.35	0.71	0.71	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	1.45	0.73	2.18	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.27	1.57	1.05	1.92	1.75	1.40	0.87	0.35	0.35	0.00
Hepatocyte, donor1	11523-119I2	56.90	6.05	2.42	0.00	4.84	1.21	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	45.25	6.46	4.31	3.23	4.31	3.23	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	61.35	5.52	3.68	3.07	1.84	1.84	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	1.31	3.26	3.26	0.65	5.87	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.29	8.56	5.94	1.75	2.45	3.15	1.75	0.87	2.27	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.89	3.70	2.88	1.78	2.61	2.88	2.47	0.55	0.82	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00	0.00	0.00	0.00	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	8.31	1.38	0.00	1.38	1.38	2.77	0.00	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	5.01	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	2.56	0.00	0.00	5.13	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	3.25	4.87	1.62	1.62	4.87	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	5.00	1.67	0.00	3.33	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	2.65	1.32	1.32	0.00	5.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	1.11	3.33	2.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	0.63	1.26	2.52	0.00	2.52	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55	0.00	3.09	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.98	1.94	1.94	3.23	0.00	3.88	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	0.00	1.61	0.00	0.00	6.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	11.95	23.90	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.00	3.26	4.07	0.00	2.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.72	0.42	1.26	0.00	0.00	0.00	0.00	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	0.80	3.21	1.61	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	1.85	0.00	2.77	0.00	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	0.94	1.89	0.94	0.00	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.00	0.00	0.00	0.00	3.63	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	2.15	0.00	4.30	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	2.54	1.27	2.54	0.00	0.00	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.01	0.00	1.28	2.55	0.00	4.46	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	0.00	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	0.71	2.14	1.43	0.00	2.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.32	1.23	0.93	0.93	0.00	0.62	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	0.00	1.76	0.00	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	0.00	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	0.00	1.39	0.00	0.00	1.39	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	0.00	2.21	0.00	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	1.74	1.74	1.74	0.00	1.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	0.00	4.50	2.25	2.25	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	1.07	0.00	1.07	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	1.39	2.77	1.39	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	5.70	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	0.92	0.92	2.76	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	6.21	0.00	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	1.06	0.00	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.13	4.08	1.63	1.22	3.59	0.82	1.06	0.98	1.06	0.41
Keratinocyte - epidermal, donor2	11349-117G8	4.10	1.17	0.59	1.17	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	25.75	4.83	3.12	1.80	0.76	2.08	0.66	0.76	0.47	0.19
Keratinocyte - oral, donor1	11251-116E9	35.64	6.02	4.99	2.50	3.75	2.27	0.57	0.79	1.36	0.23
Keratocytes, donor1	11527-119I6	7.22	1.03	0.69	0.00	0.00	0.34	0.00	0.00	0.00	0.69
Keratocytes, donor2	11607-120I5	2.34	0.00	0.00	0.00	1.17	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	16.80	0.20	1.78	1.38	0.20	1.78	0.20	0.20	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	72.53	2.20	4.40	6.59	6.59	8.79	6.59	2.20	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	3.24	2.16	0.00	5.39	3.24	3.24	1.08	1.08	3.24
Lens Epithelial Cells, donor2	11609-120I7	20.76	5.42	6.57	2.31	2.19	3.46	3.11	0.69	1.73	1.50
Lens Epithelial Cells, donor3	11690-122I7	38.85	5.25	2.42	2.42	3.23	3.13	6.16	2.32	1.11	2.93
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.09	1.54	1.19	0.24	0.36	0.36	0.24	0.12	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.33	0.84	0.84	0.84	0.00	0.56	0.56	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.10	0.94	2.83	0.79	0.94	1.42	0.94	0.63	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	1.08	0.54	0.54	0.00	0.00	0.54	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	0.32	0.63	0.00	0.00	0.00	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.79	0.86	0.54	0.75	0.22	0.65	0.11	0.00	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.31	0.82	1.23	0.82	0.41	0.82	0.41	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	0.51	0.51	0.51	0.25	0.51	0.25	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.18	1.27	0.84	0.56	0.00	0.84	0.00	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.03	0.79	0.00	0.79	1.58	1.19	0.79	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.74	0.97	1.36	0.39	0.39	1.36	0.00	0.00	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.00	0.37	1.30	0.93	0.74	0.56	0.00	0.19	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	2.09	0.70	0.00	0.70	0.70	0.00	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.97	1.67	0.48	0.72	0.00	0.24	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.46	0.55	0.55	0.55	0.00	0.82	0.55	0.27	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	1.23	2.16	0.31	0.92	1.23	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.23	1.25	0.31	0.31	0.00	1.25	0.00	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.50	1.46	0.73	0.37	0.37	0.37	0.37	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.90	2.30	0.33	1.65	0.66	1.32	1.97	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	1.76	0.88	0.29	0.29	0.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	1.00	0.50	0.00	0.25	0.50	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	2.91	2.42	0.97	3.39	0.48	1.45	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.85	1.89	1.08	0.54	1.62	2.15	1.62	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	1.21	0.76	0.76	0.15	0.76	0.61	0.15	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.89	1.04	0.00	0.52	0.52	0.52	0.52	1.04	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	24.50	1.26	1.26	2.09	0.42	0.84	1.88	0.42	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.72	1.95	0.75	0.75	1.05	0.30	0.75	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	0.69	0.00	1.38	0.69	2.75	0.00	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.91	1.51	1.32	1.13	0.56	1.51	0.38	0.19	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.62	0.74	0.42	0.53	0.42	0.53	0.32	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.66	0.48	0.00	0.48	0.97	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.25	0.99	0.66	0.33	0.99	1.98	0.99	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.33	0.62	0.99	0.74	0.74	0.37	0.50	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.44	1.11	0.74	0.74	1.48	1.85	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.60	1.48	0.74	1.73	0.49	1.24	0.99	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.19	1.24	0.55	0.14	0.41	0.55	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.15	1.61	0.96	0.96	1.93	1.61	0.00	1.29	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	0.91	0.91	0.61	0.00	1.83	0.91	1.52	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.70	1.12	1.26	0.98	0.84	0.70	0.42	1.26	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.38	1.42	0.36	0.36	1.42	1.07	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.39	1.45	0.48	0.97	0.00	1.45	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.51	0.16	0.93	0.31	0.00	0.47	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.59	1.79	1.07	0.72	0.36	1.43	0.36	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.11	1.63	2.29	0.65	0.65	0.98	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	0.47	0.24	0.47	0.24	0.71	0.24	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.43	0.99	0.74	1.11	0.74	1.11	0.12	0.50	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	0.51	0.26	1.02	0.51	1.02	0.00	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	0.30	0.60	0.30	0.00	0.90	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	6.80	0.00	0.00	13.60	2.27	11.33	4.53	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	4.60	4.60	6.14	3.07	3.84	1.53	3.84	0.00	5.37
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	3.71	0.00	3.71	6.68	1.48	5.94	5.94	0.74	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.62	3.39	3.81	2.96	5.92	2.54	2.54	4.23	1.27	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.88	4.92	2.11	2.11	2.81	3.52	1.41	2.81	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	3.74	0.00	3.74	5.60	0.93	0.93	0.93	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	2.06	2.58	1.55	7.21	1.55	2.06	5.67	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	3.57	2.38	2.38	4.76	3.57	1.19	2.38	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.85	2.71	1.81	1.58	7.01	2.26	2.26	3.39	0.45	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.58	4.07	1.74	2.33	5.82	2.04	2.33	7.85	0.00	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.61	8.10	2.25	5.40	7.65	4.05	6.75	4.95	2.25	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.52	5.01	2.98	3.39	9.75	2.30	4.74	3.66	1.90	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.65	2.05	2.57	2.05	6.68	1.03	2.05	6.16	0.51	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.82	4.59	2.47	3.18	7.76	2.47	3.53	2.82	1.41	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	10.66	3.33	0.67	2.67	4.66	2.00	2.67	2.67	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	1.53	4.08	2.55	2.55	0.51	4.58	6.62	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.41	4.00	2.40	1.60	6.40	4.00	3.74	4.80	1.60	3.20
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.10	6.05	3.59	4.35	7.56	2.83	3.97	4.72	1.13	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	23.93	3.07	2.45	4.91	4.91	4.91	2.45	6.14	0.61	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	15.49	4.08	5.71	2.45	4.89	1.63	4.89	4.08	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.36	3.75	3.33	3.75	7.71	2.50	4.58	5.41	0.83	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.26	4.48	3.36	1.96	5.61	2.52	4.76	8.97	1.40	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	21.64	0.00	2.06	4.12	8.24	4.12	6.18	3.09	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	23.51	7.84	4.06	4.64	7.26	2.90	5.81	5.81	2.61	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	22.12	5.98	2.39	2.69	5.98	3.59	3.29	5.08	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	6.09	0.55	2.77	7.75	4.98	6.64	4.98	2.77	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.98	5.66	4.60	4.60	5.30	2.12	3.89	3.18	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.71	5.53	2.95	4.06	9.22	2.58	5.16	8.11	2.58	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	21.87	6.91	0.00	5.76	2.30	4.61	2.30	2.30	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	25.33	3.84	2.30	4.61	5.76	3.07	3.84	7.68	1.54	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.81	2.26	3.40	2.83	7.36	1.70	2.83	3.96	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	25.43	3.28	4.92	4.10	4.10	4.10	4.92	4.92	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	3.16	3.16	3.16	4.97	1.81	3.16	4.52	1.36	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	2.87	2.15	3.59	5.03	5.03	2.15	4.31	0.72	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	27.64	6.72	4.48	4.48	6.72	5.23	11.20	4.48	1.49	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.30	5.95	2.97	2.23	5.95	2.60	6.69	7.43	1.86	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	5.60	1.72	3.45	3.45	1.72	5.60	7.75	1.29	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	5.14	1.71	3.43	5.99	5.99	4.28	5.14	2.57	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.66	2.67	3.00	4.00	6.00	2.00	2.00	6.00	1.00	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.31	4.83	3.02	4.83	7.24	3.62	1.21	3.62	0.00	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	20.62	3.55	2.84	2.84	3.55	2.84	3.55	3.55	0.71	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.37	3.78	1.37	3.09	6.53	3.78	1.72	4.12	0.34	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	1.61	1.61	1.61	5.90	1.61	3.22	4.29	1.07	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.28	2.69	2.02	3.37	2.69	4.71	1.35	2.69	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.37	4.07	1.11	2.96	4.82	1.11	2.59	3.33	1.85	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	4.65	4.65	2.33	8.14	2.33	5.81	6.98	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	3.17	0.00	3.17	1.06	3.17	2.12	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.01	4.00	2.40	3.60	5.60	3.20	4.00	5.20	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.07	0.73	2.18	4.36	2.91	1.45	2.91	3.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	4.60	0.00	1.53	12.26	1.53	1.53	3.07	0.77	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	2.96	2.47	1.97	4.44	3.45	1.48	3.45	1.97	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	3.76	0.94	1.88	2.82	1.88	1.88	3.76	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	3.02	2.01	4.53	5.03	7.04	2.01	3.52	1.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.69	3.60	3.60	3.60	6.76	4.06	3.15	4.06	0.90	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	1.72	0.00	3.44	1.72	1.72	1.72	5.16	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.05	3.56	2.23	4.01	9.35	5.34	4.90	2.67	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	22.68	4.69	1.56	3.91	7.04	5.08	1.96	5.08	2.35	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.77	3.96	0.00	0.66	3.96	3.30	0.66	3.30	1.32	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.09	6.75	3.11	5.19	5.19	5.19	6.75	1.56	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	3.94	3.06	3.06	4.81	3.06	2.63	5.25	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	1.68	3.91	3.91	6.15	5.03	4.47	7.83	1.68	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.50	1.77	2.21	6.62	5.74	3.53	4.42	5.30	1.32	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.30	2.31	1.54	1.54	7.33	3.86	2.70	3.47	1.16	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	5.57	1.01	3.54	8.61	4.05	3.04	4.05	1.52	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.91	6.73	1.92	2.88	4.81	4.81	4.33	7.69	0.96	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	28.62	5.96	2.78	3.98	7.16	3.98	1.99	6.36	0.80	3.18
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.87	7.29	5.47	2.43	7.29	4.25	3.65	8.51	3.04	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	2.77	4.15	1.38	6.92	2.77	5.53	2.08	0.69	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.20	7.60	3.42	2.28	6.84	3.42	4.18	6.84	1.14	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	23.24	3.61	6.71	3.61	4.13	2.58	1.55	8.26	1.55	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.79	1.81	1.81	4.23	9.07	4.84	6.05	6.05	0.60	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	29.47	5.39	2.85	4.12	10.14	2.22	4.75	7.29	1.58	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	2.13	3.73	9.60	10.13	5.33	2.13	11.19	2.13	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	20.69	3.45	2.30	8.05	6.90	5.17	1.72	8.62	1.72	2.87
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	7.71	1.03	4.63	5.66	4.11	1.54	7.71	3.09	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	7.07	1.41	2.12	4.95	2.83	4.24	7.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	29.51	4.54	5.11	5.67	5.67	3.40	6.81	4.54	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	21.63	2.91	3.74	5.82	7.49	2.91	4.16	7.49	0.83	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	3.13	1.57	3.13	5.48	3.13	1.57	9.40	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.71	3.76	3.34	3.76	4.18	3.34	4.59	7.93	0.84	4.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.16	4.18	1.86	3.72	7.90	5.11	5.11	6.50	1.86	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	15.39	3.35	6.02	6.02	5.35	5.35	2.01	8.03	2.01	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	32.08	3.21	5.35	4.28	9.09	3.21	6.42	4.81	1.60	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.29	3.64	2.83	4.85	5.66	6.47	3.64	6.47	1.21	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	2.75	4.59	3.67	1.84	1.84	1.84	8.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	4.45	5.33	4.45	8.00	1.78	2.67	10.67	1.78	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.35	3.99	1.71	6.27	11.97	5.70	3.99	9.12	0.57	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	1.53	3.83	3.83	5.37	4.60	3.07	3.07	3.83	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.91	1.09	4.38	3.28	7.66	3.28	2.19	3.83	3.28	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.40	5.79	2.23	8.91	8.91	1.78	4.90	4.45	0.89	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.53	5.46	3.90	2.60	9.36	2.60	3.12	3.64	1.30	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	30.50	3.98	3.32	6.63	3.32	4.64	7.29	3.98	1.33	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	41.57	6.24	2.08	2.08	2.08	4.16	6.24	6.24	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	25.07	2.05	1.60	1.37	1.37	0.68	0.00	0.91	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	13.21	1.65	1.47	1.84	1.65	2.75	0.00	2.20	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	20.84	1.97	1.44	1.57	1.97	1.18	0.13	1.97	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.18	4.25	2.12	0.53	6.90	2.66	1.59	2.66	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	24.08	3.33	2.22	1.27	9.03	0.63	2.69	1.58	0.95	0.79
Mallassez-derived cells, donor3	11930-125I4	41.97	7.09	4.17	1.67	13.06	3.75	4.59	2.36	1.11	1.11
Mammary Epithelial Cell, donor1	11273-116H4	42.15	4.78	1.59	1.00	3.59	0.60	0.60	0.90	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	28.09	5.50	1.74	1.45	4.05	1.74	0.29	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.21	2.49	0.50	0.50	1.50	0.25	0.75	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	83.39	5.42	5.42	5.42	32.54	5.42	27.12	58.98	4.07	12.20
Mast cell, donor1	11563-120D6	42.61	4.22	7.35	3.68	1.41	4.33	0.76	1.08	0.54	0.11
Mast cell, donor2	11565-120D8	115.90	16.34	16.64	9.21	5.05	9.81	2.67	2.08	3.57	0.30
Mast cell, donor3	11566-120D9	156.91	12.16	14.41	11.48	9.00	11.03	5.18	5.40	1.58	1.13
Mast cell, donor4	11567-120E1	133.32	11.17	15.78	6.91	8.69	6.21	3.72	2.13	1.77	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	24.51	2.88	5.10	3.99	0.44	2.00	0.22	1.11	0.67	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	7.59	4.67	5.25	1.17	3.50	1.75	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	30.29	3.56	4.82	3.44	0.34	2.87	0.11	0.46	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	60.42	5.69	8.54	7.03	2.85	4.35	0.67	2.18	1.17	0.17
Melanocyte - dark, donor1	11502-119F8	28.85	4.68	2.29	1.39	0.70	2.98	0.60	0.20	0.30	0.00
Melanocyte - dark, donor2	11582-120F7	11.07	1.73	1.38	1.04	0.69	1.73	0.35	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	29.27	3.19	2.97	1.45	0.58	1.52	0.58	0.00	0.36	0.00
Melanocyte - light, donor1	11274-116H5	13.16	0.94	0.47	0.94	0.24	0.47	0.00	0.24	0.24	0.00
Melanocyte - light, donor2	11351-117H1	6.82	0.00	0.68	1.36	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	9.54	0.00	0.00	0.00	0.00	0.87	0.00	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	18.33	0.83	1.04	1.56	0.10	1.46	0.52	0.31	0.42	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	20.98	1.61	0.54	0.81	1.08	0.81	0.27	0.27	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	36.96	3.48	1.87	1.34	1.07	2.41	1.34	0.54	0.27	0.27
Meningeal Cells, donor1	11493-119E8	18.98	1.49	2.23	1.61	0.74	0.99	1.86	0.25	0.74	0.62
Meningeal Cells, donor2	11573-120E7	11.44	0.88	1.76	0.44	0.44	1.76	1.76	0.00	0.00	1.76
Meningeal Cells, donor3	11654-122E7	37.00	4.97	2.61	1.71	1.87	2.20	2.77	0.65	1.06	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.39	3.14	2.85	1.71	0.57	2.00	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.76	5.03	3.12	1.41	4.13	1.01	1.31	1.11	1.41	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	3.92	2.62	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	1.44	2.87	0.00	2.15	0.72	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	34.09	6.56	4.02	2.33	8.26	2.54	4.45	2.33	1.48	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	6.03	3.52	4.02	8.04	3.02	3.52	2.01	2.01	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.93	0.44	0.66	0.44	0.00	0.22	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	1.46	0.73	1.46	1.46	0.73	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.96	0.61	0.20	1.23	0.00	1.23	0.20	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.73	1.66	2.91	0.83	1.11	0.69	0.83	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.37	0.74	0.00	0.37	0.37	0.74	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.68	4.34	2.37	0.92	2.50	1.32	0.53	0.79	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.01	1.19	0.89	0.30	1.19	0.59	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	1.28	1.28	0.00	0.00	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.29	4.25	3.19	1.42	1.77	1.77	1.06	1.06	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.52	2.81	1.88	0.94	4.07	0.94	1.25	0.94	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	2.18	2.18	4.35	1.45	2.18	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	12.46	1.33	3.98	1.33	0.80	1.33	0.00	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	5.51	3.00	1.50	2.50	1.00	1.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.85	2.53	3.04	1.59	0.94	1.66	0.14	0.58	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	66.17	1.35	1.35	0.00	2.70	1.35	1.35	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	36.20	3.45	0.99	2.22	1.72	1.72	0.00	1.72	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.50	3.53	1.18	0.88	1.18	2.94	0.29	3.83	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	62.23	0.00	0.00	3.46	6.91	0.00	0.00	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	27.59	2.48	0.62	1.24	0.62	1.24	0.31	0.62	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.61	1.04	1.45	2.28	1.04	1.04	0.21	0.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	76.43	0.00	2.32	4.63	0.00	0.00	0.00	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.53	3.00	1.75	2.25	2.25	1.00	0.25	2.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	1.40	0.93	2.33	1.86	0.93	0.00	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.71	1.42	1.63	2.44	0.61	0.81	0.00	1.83	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	3.56	1.19	0.79	0.40	1.19	0.79	1.58	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	0.00	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	0.00	0.88	1.77	0.00	0.88	0.00	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.72	1.14	1.14	1.14	0.38	1.14	0.76	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	51.32	0.00	0.00	0.00	3.95	0.00	0.00	5.26	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.22	1.91	1.06	1.27	0.85	0.85	0.00	0.21	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	0.92	0.00	0.00	0.00	0.00	0.92	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.11	2.98	0.89	0.89	1.19	1.79	0.00	1.19	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	3.35	1.68	1.68	3.35	0.00	0.00	5.03	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.03	0.75	0.50	1.00	0.25	1.00	0.00	1.51	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.69	3.33	2.38	0.95	0.95	0.95	0.00	1.19	0.95	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	25.43	4.42	1.66	0.55	2.76	0.00	0.00	2.76	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	1.38	1.84	1.38	1.84	0.69	0.00	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.15	2.52	0.84	1.68	0.42	1.47	0.42	0.21	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.97	2.65	1.63	1.43	0.82	0.61	0.20	0.41	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.87	0.86	0.86	0.64	1.07	1.07	0.21	0.86	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.12	2.00	0.89	1.11	0.22	1.56	0.44	1.11	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.26	1.97	0.66	0.44	0.66	0.44	0.00	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.28	2.03	0.51	0.51	1.52	1.01	0.00	1.01	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	0.00	1.66	0.00	3.31	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.07	1.63	0.54	1.09	0.82	0.54	0.00	0.27	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	1.76	1.76	2.06	0.00	1.47	0.00	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	3.27	0.00	0.00	3.27	0.00	0.00	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	1.92	1.44	0.00	0.96	1.44	0.48	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	2.00	2.00	1.60	0.40	0.00	0.40	1.60	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	2.74	0.00	0.00	0.00	0.00	0.00	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.00	0.50	1.50	1.00	0.50	2.50	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	2.04	0.00	4.08	0.00	0.00	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.20	0.88	0.44	0.88	0.00	0.88	0.00	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	3.31	0.00	2.21	3.31	1.10	0.00	3.31	1.10	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	21.77	1.28	0.00	0.64	1.28	1.28	0.00	3.20	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.69	1.49	1.74	1.24	0.50	1.98	0.25	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	0.70	0.70	0.00	0.00	1.39	0.70	4.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	2.21	0.00	0.00	2.21	0.00	2.21	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	1.37	1.03	1.71	0.68	1.37	0.68	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.94	3.06	0.88	2.19	1.75	1.31	1.31	2.19	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	25.21	1.07	0.36	0.71	1.78	1.78	0.71	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.66	0.56	1.40	1.12	1.12	0.84	0.28	0.84	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.69	2.91	1.66	0.83	1.25	2.49	0.42	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.14	0.00	2.91	0.58	1.17	0.58	0.00	4.66	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.67	2.71	2.11	0.90	1.21	0.60	0.00	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.94	1.25	1.67	1.25	0.00	2.50	0.83	1.67	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	21.66	7.22	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	5.54	1.85	1.85	0.92	6.46	1.85	2.77	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	30.16	3.41	1.71	1.71	1.14	1.71	1.14	3.98	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.62	2.21	1.24	1.93	1.93	0.83	0.55	2.21	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.29	2.33	2.59	2.85	1.30	1.55	0.78	1.30	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	25.74	2.57	0.86	1.72	1.72	1.29	0.00	3.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.14	1.27	1.91	3.18	3.81	1.91	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.21	2.40	2.94	1.07	1.60	1.07	0.53	1.07	1.60	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.05	4.19	3.29	2.39	2.10	2.39	0.30	2.10	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.29	3.53	1.98	1.41	1.55	1.70	0.57	0.85	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.73	1.27	1.59	1.59	2.23	1.59	0.00	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.13	2.87	3.10	2.87	1.77	1.11	0.66	2.43	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	2.65	0.76	1.52	1.90	1.90	1.14	1.52	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.51	3.13	3.13	2.56	1.70	1.14	0.00	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.24	2.95	3.20	3.69	1.23	2.70	0.00	0.98	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.98	0.65	1.96	1.30	3.91	1.30	0.00	1.30	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.23	2.65	3.23	1.76	2.06	1.47	0.29	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	21.62	3.17	2.59	2.59	2.59	3.17	0.86	1.73	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	29.67	3.71	7.42	1.65	1.24	0.41	0.82	0.41	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.46	3.57	2.08	2.38	1.19	2.68	0.00	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	1.78	0.00	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.81	0.99	0.99	0.99	0.66	0.33	0.00	0.99	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	2.10	1.05	2.10	0.00	1.05	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.33	1.19	0.99	1.19	0.59	0.40	0.59	0.20	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	20.49	0.93	0.00	0.00	0.00	0.93	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.77	0.00	0.00	0.00	0.00	0.75	0.00	0.75	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.25	0.27	1.33	0.53	0.80	1.60	0.27	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.70	2.15	0.90	0.57	0.68	0.34	0.34	0.45	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.00	0.74	0.74	0.74	0.00	0.74	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.39	0.37	0.37	0.73	0.73	1.10	0.00	1.47	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	1.56	1.56	1.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.90	1.60	1.60	0.53	0.53	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	1.01	0.00	1.01	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.23	1.26	0.84	0.84	0.00	2.53	0.84	1.69	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	0.00	0.00	0.00	5.45	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	1.27	0.00	1.27	1.27	0.00	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	6.48	0.00	0.81	1.62	0.00	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	1.51	0.00	6.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	5.71	5.71	0.00	28.55	0.00	5.71	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	3.26	3.26	9.79	0.00	0.00	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75	4.75	4.75	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	25.10	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.71	1.51	1.29	1.08	0.65	0.86	0.22	0.00	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.75	1.05	1.05	1.57	0.00	0.52	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	30.04	0.67	2.00	3.34	1.33	2.00	2.00	2.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.15	2.92	1.25	7.51	3.76	4.59	3.34	2.09	0.42	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	20.54	1.90	1.71	3.99	3.42	3.42	2.66	1.14	0.38	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	54.26	1.60	0.00	1.60	1.60	1.60	3.19	1.60	6.38	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	15.64	0.68	0.68	5.44	0.68	1.36	0.68	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	55.13	18.38	1.84	3.68	20.21	3.68	11.03	9.19	1.84	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	2.09	1.26	2.93	0.00	1.26	0.42	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.75	1.63	1.86	4.18	2.79	3.49	1.63	3.25	0.46	2.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.62	1.62	1.62	2.97	0.81	0.81	0.27	0.27	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.97	1.05	1.26	2.31	0.42	1.26	0.63	0.00	0.42	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	22.27	0.00	0.00	11.13	0.00	11.13	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.34	0.99	1.99	1.49	0.99	1.99	0.00	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.43	2.17	1.08	1.62	1.35	1.62	1.08	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.79	1.81	1.36	2.95	1.36	2.49	1.13	2.04	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.09	0.98	1.31	2.94	0.33	1.31	0.65	0.65	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.96	2.73	1.46	1.09	2.19	1.46	1.09	0.18	0.00	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	1.06	1.06	3.18	0.53	1.59	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	0.60	1.20	3.60	1.20	1.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	24.61	3.28	1.64	2.30	0.98	2.63	2.63	0.33	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.30	1.46	1.14	2.76	0.65	1.95	1.14	1.30	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.28	3.35	1.94	1.06	1.41	2.65	1.23	0.35	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	1.41	0.00	7.03	0.00	2.81	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.90	1.84	1.38	4.14	0.92	0.92	1.38	0.46	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.21	2.25	1.93	4.50	0.32	1.61	0.96	0.32	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.38	4.14	2.07	3.10	6.90	1.72	1.72	0.69	1.03	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	40.46	45.51	10.11	5.06	12.64	2.53	2.53	0.00	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	35.65	3.56	1.78	2.67	2.01	2.01	1.56	1.56	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	18.21	2.96	0.42	0.85	1.27	2.54	0.42	0.42	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.17	1.42	2.61	2.61	1.42	1.19	1.19	0.24	0.47	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	0.43	0.86	2.15	0.86	1.72	0.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	0.00	9.03	0.00	27.08	9.03	18.06	0.00	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.66	3.33	3.00	5.33	0.33	3.00	1.00	0.67	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.19	2.71	0.45	1.35	1.80	0.90	0.90	0.90	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	2.38	1.59	1.59	0.00	1.59	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	0.93	0.93	1.86	0.93	0.93	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	2.65	1.51	4.54	1.51	2.65	0.38	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.60	2.61	2.28	2.93	0.98	2.61	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.97	5.23	2.18	5.23	0.44	2.61	1.31	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	3.17	3.17	2.71	1.81	2.71	1.81	0.00	1.36	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	1.76	2.65	1.76	0.00	2.65	0.00	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	30.58	0.66	2.66	4.65	1.33	1.99	3.32	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	2.98	2.48	0.50	1.49	0.50	1.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.59	3.45	1.53	1.91	1.15	1.91	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.01	3.93	3.33	4.84	2.72	3.63	1.21	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.12	2.87	1.77	1.33	2.21	1.99	0.44	0.00	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	0.68	0.68	2.71	0.00	3.39	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	66.42	20.44	0.00	10.22	10.22	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	24.39	3.66	1.83	6.10	0.00	3.05	1.22	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.40	2.20	2.20	3.78	0.94	3.15	0.94	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.15	2.12	3.63	3.03	1.51	6.36	0.91	0.91	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	3.96	1.58	0.79	0.00	3.96	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	6.80	3.40	6.80	1.13	5.67	2.27	0.00	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	10.12	5.06	0.00	5.06	5.06	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	20.75	2.98	1.86	1.24	4.35	1.37	0.62	1.49	0.12	0.12
Myoblast, donor2	11322-117D8	22.82	4.22	2.88	1.73	2.11	1.73	0.77	0.77	0.19	0.38
Myoblast, donor3	11398-118D3	18.33	1.85	2.86	1.85	1.01	0.84	1.01	0.50	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.42	1.61	3.50	2.33	0.44	3.06	0.29	0.29	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	5.54	2.15	8.00	4.31	0.00	4.61	0.31	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	1.21	1.21	5.13	3.32	0.00	3.62	0.00	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	4.42	2.39	9.94	2.76	0.18	6.81	0.18	0.37	0.55	0.37
Neural stem cells, donor1	11275-116H6	97.27	33.39	17.06	14.88	16.33	6.53	9.44	7.62	6.53	11.98
Neural stem cells, donor2	11352-117H2	32.74	3.85	11.55	11.55	9.63	7.70	3.85	1.93	3.85	9.63
Neurons, donor1	11494-119E9	11.38	7.97	2.28	5.69	0.00	4.55	4.55	0.00	0.00	1.14
Neurons, donor2	11574-120E8	9.69	3.30	3.74	4.40	0.66	1.10	0.88	0.44	0.44	0.66
Neurons, donor3	11655-122E8	13.15	2.47	4.11	9.04	1.64	4.93	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	43.62	5.57	18.56	6.50	1.86	6.50	0.93	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	43.48	5.80	8.70	2.90	2.90	11.60	2.90	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	80.02	17.71	20.16	12.22	7.94	13.44	3.67	3.05	3.67	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	17.93	3.44	3.44	2.26	0.59	0.83	0.47	0.24	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	15.30	1.30	0.33	1.95	0.33	0.65	0.33	0.00	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	16.24	1.60	1.80	2.61	0.00	1.00	0.80	0.00	0.80	0.00
Olfactory epithelial cells, donor1	11933-125I7	15.00	0.96	1.93	0.41	0.41	0.69	0.14	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	17.66	2.17	1.59	0.58	0.72	0.87	0.43	0.87	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	19.41	1.93	1.36	0.79	1.48	0.68	0.00	0.00	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	40.32	4.77	2.63	2.05	1.27	1.46	0.49	0.68	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	25.88	3.01	3.61	2.41	2.41	4.21	0.00	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	12.76	1.28	2.55	0.64	1.49	2.13	0.43	0.21	0.00	0.64
Osteoblast - differentiated, donor2	11353-117H3	5.72	1.14	0.00	1.14	0.00	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.31	0.00	0.62	0.62	0.62	0.62	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	7.82	1.56	1.76	0.20	0.20	0.20	0.59	0.00	0.20	0.78
Osteoblast, donor2	11354-117H4	9.83	3.51	2.81	2.81	0.00	0.70	0.00	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	22.22	3.02	3.02	1.78	1.07	2.13	1.07	0.36	0.00	0.71
Pancreatic stromal cells, donor1	11249-116E7	30.49	3.62	2.02	1.01	2.36	1.60	1.10	1.18	0.67	0.42
Pericytes, donor1	11491-119E6	4.56	0.11	0.22	0.56	0.11	0.33	0.56	0.22	0.11	0.22
Pericytes, donor2	11571-120E5	6.34	0.23	0.68	1.58	0.00	0.45	1.81	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	6.51	1.22	0.81	1.02	0.41	1.42	0.41	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	33.91	5.09	2.71	2.15	2.60	2.94	4.29	0.57	1.13	1.70
Perineurial Cells, donor2	11579-120F4	22.17	2.21	0.83	0.55	1.84	0.74	0.55	0.55	0.46	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	31.56	4.46	6.69	7.33	1.27	3.51	0.00	0.96	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.04	6.12	4.16	3.43	1.71	3.43	0.24	1.47	1.71	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.34	4.92	6.21	4.92	0.65	4.40	0.26	1.04	0.65	0.39
Placental Epithelial Cells, donor1	11278-116H9	13.87	0.72	0.48	0.96	1.20	1.67	0.48	0.00	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	11.09	4.44	1.11	0.00	2.22	1.11	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.25	0.98	0.20	0.59	0.59	0.59	0.39	0.39	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	0.95	1.90	1.90	0.32	0.32	0.00	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	13.69	2.81	1.31	1.88	3.56	1.31	0.56	0.56	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.53	1.83	0.91	1.17	1.83	0.91	0.39	0.39	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	11.48	1.35	2.25	1.13	0.90	0.68	0.68	0.23	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	13.00	2.24	2.24	0.96	1.70	0.75	0.53	0.43	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	12.66	2.62	1.31	1.75	2.62	0.44	0.87	1.75	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	18.48	2.72	2.44	1.72	1.43	3.44	0.57	0.72	0.43	0.00
Preadipocyte - perirenal, donor1	11469-119C2	2.95	0.00	1.97	0.00	3.94	0.00	0.00	0.98	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	15.66	1.54	0.61	1.23	0.00	0.92	0.61	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	40.90	5.31	3.72	3.54	4.25	2.30	1.95	0.53	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	11.75	1.70	2.04	0.85	2.04	1.02	0.00	0.51	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	41.17	3.54	1.86	1.58	3.54	1.68	1.40	0.93	0.65	0.56
Preadipocyte - visceral, donor2	11357-117H7	35.89	3.22	1.84	0.92	4.60	0.46	1.38	2.30	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	21.21	1.04	1.25	1.25	2.40	0.84	1.04	0.73	0.21	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.80	4.98	4.83	3.17	2.26	1.51	2.56	0.15	0.91	0.91
Prostate Epithelial Cells, donor2	11331-117E8	16.79	3.52	2.98	1.76	3.93	1.62	2.03	0.95	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	21.31	5.39	3.43	1.90	0.24	2.57	0.67	0.24	0.73	0.18
Prostate Stromal Cells, donor1	11254-116F3	23.58	4.10	3.08	2.16	2.39	1.94	1.37	0.23	0.68	0.23
Prostate Stromal Cells, donor2	11332-117E9	36.94	11.12	6.81	5.02	4.12	5.74	3.94	1.43	2.15	1.43
Prostate Stromal Cells, donor3	11405-118E1	26.38	3.55	1.67	1.25	2.29	1.77	2.61	0.83	0.31	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.47	0.73	1.46	1.46	0.73	3.28	2.19	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.57	4.44	4.78	5.13	1.25	5.68	0.55	0.42	1.11	0.55
Renal Epithelial Cells, donor1	11517-119H5	11.67	2.03	0.51	1.01	0.00	1.01	0.51	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	1.42	2.85	1.42	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	33.03	7.94	4.13	2.43	3.18	2.01	2.43	0.95	0.74	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.94	0.00	0.00	0.00	0.68	2.04	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.85	1.21	1.35	0.67	0.81	2.56	1.08	0.40	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	34.63	3.11	5.11	3.11	2.66	4.00	2.22	1.11	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	0.00	0.67	2.00	0.67	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.02	2.64	1.98	1.32	0.66	1.98	3.08	0.66	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	4.39	1.25	1.25	1.25	0.00	1.25	0.63	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.61	0.83	0.28	0.83	0.28	1.66	0.28	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.96	2.42	3.49	1.07	1.07	2.15	0.00	0.27	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	0.84	1.27	0.84	0.00	0.84	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.76	2.51	0.77	1.54	0.19	1.54	0.39	0.39	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.11	4.67	3.89	2.59	0.00	2.07	0.26	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	1.99	1.42	2.56	1.14	1.99	0.57	0.57	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	0.00	0.00	1.03	0.00	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.52	3.51	4.77	1.25	0.50	1.00	0.00	0.50	0.75	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	105.71	9.49	6.55	3.61	9.35	3.88	4.54	1.20	1.60	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	11.61	1.79	3.57	1.79	0.00	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	2.75	0.00	0.55	1.10	0.55	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.02	2.90	1.74	0.58	1.16	0.00	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.39	1.04	2.34	1.69	1.43	1.56	0.39	0.00	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	13.51	2.68	2.38	1.39	0.30	1.89	0.30	0.10	0.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.29	3.68	4.80	2.01	1.34	1.67	0.22	0.11	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.13	2.85	3.47	1.61	0.50	2.11	0.62	0.25	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.55	2.68	2.21	2.80	0.58	2.21	0.23	0.58	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.25	2.08	4.85	1.62	0.23	2.77	0.23	0.00	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.41	1.10	2.60	1.37	0.96	1.51	0.41	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	11.04	1.51	2.72	1.97	0.45	1.36	0.30	0.00	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.95	2.15	3.94	1.79	1.25	2.33	0.18	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.19	1.86	4.45	1.86	1.15	1.86	0.43	0.43	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.13	1.50	1.82	1.61	0.75	1.40	0.21	0.21	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	14.16	1.11	2.88	2.21	0.66	1.33	0.66	0.44	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.94	2.49	3.44	2.87	1.34	1.72	0.19	0.38	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.63	2.05	3.45	2.14	0.75	1.40	0.09	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	16.72	5.07	4.13	2.82	1.13	0.38	0.19	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.47	1.73	4.25	1.86	1.19	2.26	0.40	0.53	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.73	3.11	3.70	3.21	0.78	1.65	0.39	0.10	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.94	3.25	4.20	3.82	0.57	1.72	0.19	0.19	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.52	2.14	4.16	1.50	1.28	2.46	0.43	0.43	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	9.53	1.68	2.80	2.52	0.56	2.24	0.56	0.00	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	12.82	2.91	4.79	1.88	1.20	2.56	0.68	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	2.73	4.19	2.37	0.55	2.37	0.55	0.36	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	9.32	1.35	2.08	1.59	0.74	1.59	0.00	0.37	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	12.89	3.76	3.36	2.15	0.94	1.21	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.43	1.65	4.01	1.65	1.65	0.94	0.94	0.47	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.52	2.38	3.37	1.39	0.40	2.38	0.00	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.16	1.87	5.14	4.44	0.94	1.87	0.00	0.23	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.20	2.28	4.56	2.07	0.62	2.28	0.21	0.21	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	7.96	1.55	4.20	2.21	0.88	1.77	0.22	0.22	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.50	2.72	1.88	3.34	0.84	2.51	0.21	0.42	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.55	2.02	4.71	2.02	1.48	2.15	0.94	0.54	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.16	3.75	3.07	1.53	1.36	1.53	0.34	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	20.82	3.28	3.86	2.89	0.58	2.51	0.19	0.19	0.96	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.72	1.72	5.16	1.38	0.52	2.92	0.69	0.17	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.81	3.29	4.25	2.74	0.41	1.78	0.27	0.41	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	19.21	4.27	4.27	1.97	1.64	1.31	0.33	0.33	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	14.49	2.39	3.75	1.36	1.53	2.73	0.34	0.17	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.16	2.66	5.62	2.52	1.04	1.92	0.15	0.00	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	20.26	3.47	3.47	1.07	0.80	2.13	0.80	0.00	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.10	1.94	2.63	1.52	0.55	2.21	0.41	0.14	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.71	2.38	3.81	1.67	0.95	1.67	0.24	0.00	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	22.77	4.84	3.83	2.82	1.81	2.42	0.81	0.40	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.35	1.60	1.98	1.88	0.85	1.32	0.19	0.09	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.23	1.40	2.10	2.10	0.00	0.35	0.35	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.74	2.72	3.02	0.91	1.21	1.81	0.60	0.60	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.01	1.47	2.94	0.73	1.22	1.71	0.37	0.24	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	34.20	5.09	4.80	2.18	1.60	2.47	0.44	0.15	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.39	1.22	5.48	1.22	0.00	3.65	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.86	0.90	4.52	1.21	0.30	2.71	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	17.19	1.36	1.58	1.58	1.36	0.90	0.00	0.00	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	18.27	3.29	3.59	2.40	1.20	1.80	0.60	0.00	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.05	1.89	2.13	0.83	1.30	1.42	0.47	0.24	1.06	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.50	3.42	2.13	1.71	0.64	1.71	0.21	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	1.80	5.41	1.80	1.80	3.00	0.00	1.80	0.00	0.60
Schwann Cells, donor1	11498-119F4	7.52	1.13	1.32	1.69	0.19	1.13	1.13	0.19	0.75	0.19
Schwann Cells, donor2	11578-120F3	10.21	6.80	3.40	0.00	3.40	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.34	3.94	1.31	2.41	1.31	1.97	1.10	0.44	0.22	0.88
Sebocyte, donor1	11220-116B5	28.48	1.64	2.74	2.19	3.29	1.64	2.74	1.64	1.10	0.00
Sebocyte, donor2	11301-117B5	7.81	1.38	1.84	0.46	0.92	0.00	0.46	1.38	0.46	0.46
Sebocyte, donor3	11378-118B1	6.60	1.03	1.03	0.41	0.21	0.00	0.21	0.21	0.41	0.00
Sertoli Cells, donor1	11255-116F4	23.19	6.63	0.00	3.31	0.00	0.00	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	22.59	0.00	0.00	0.00	2.82	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	7.83	1.58	2.73	1.06	0.26	1.41	0.18	0.00	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.72	0.00	0.00	0.00	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	9.20	0.84	2.51	3.34	0.84	4.18	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.94	0.94	1.57	1.73	0.16	1.57	0.16	0.47	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	12.34	0.89	1.04	1.64	0.59	1.04	0.30	0.00	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	18.62	2.77	2.77	3.23	0.31	1.85	0.62	0.31	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	17.14	1.01	1.89	1.13	0.38	1.13	0.50	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.70	1.00	2.57	1.28	0.00	1.00	0.14	0.29	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	20.83	2.18	2.98	1.49	0.20	2.98	0.20	0.40	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.25	1.85	2.27	2.02	0.17	1.10	0.17	0.00	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	2.17	1.45	0.72	0.72	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.25	2.06	1.65	1.10	1.65	1.24	4.13	1.38	0.55	1.93
Skin - palm, donor1	10286-104F7	96.70	0.00	0.00	10.74	13.43	0.00	2.69	5.37	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.80	1.01	1.73	1.44	0.72	0.43	0.58	0.43	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	19.63	7.36	5.73	3.27	12.27	3.27	4.09	4.09	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.33	2.21	1.17	1.17	1.17	1.04	0.52	0.13	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	20.85	4.31	2.78	1.25	3.61	0.97	0.00	0.56	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	20.54	3.09	0.98	2.53	2.81	1.27	0.98	1.27	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	88.38	9.52	7.40	3.38	10.78	3.38	4.44	1.90	1.90	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	29.53	3.75	2.77	1.80	1.27	1.80	0.45	0.52	0.60	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.82	2.47	3.09	1.54	3.39	1.23	0.93	2.16	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.12	0.89	1.11	0.67	4.00	0.89	2.22	2.00	1.56	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.98	5.29	2.35	0.00	5.29	1.18	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.17	2.65	2.43	0.22	0.00	0.44	0.22	1.10	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.91	1.97	0.39	0.00	1.97	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	4.64	3.86	0.77	3.86	2.32	0.77	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	35.03	6.00	2.00	1.00	3.00	3.00	5.00	1.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.64	2.13	1.06	0.67	1.60	0.67	0.27	0.40	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.64	2.66	1.77	1.33	1.11	1.55	0.00	0.89	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.97	2.82	2.18	1.41	2.56	1.28	1.41	1.15	0.64	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.21	1.95	0.33	0.98	0.33	0.65	0.00	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.13	2.95	2.07	1.48	0.89	1.18	0.59	0.00	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.36	2.28	2.28	1.14	0.43	1.28	0.71	0.71	0.14	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.39	0.65	0.49	0.16	0.33	0.33	0.65	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.79	2.13	1.83	0.91	0.30	0.30	0.30	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.59	1.01	0.76	0.25	0.51	1.01	0.25	0.76	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	0.48	0.00	0.00	0.00	0.95	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	1.77	2.21	1.47	2.36	1.18	0.74	1.33	0.74	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	16.79	1.94	1.72	2.37	1.51	1.29	0.43	1.51	0.00	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.71	3.46	1.47	1.78	1.89	1.47	2.10	0.73	0.63	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.66	0.93	1.08	0.00	0.46	0.93	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	4.31	3.23	2.16	4.31	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.76	1.49	1.79	0.30	0.60	0.00	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	2.73	0.34	0.68	0.34	0.00	0.00	0.00	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.67	2.04	2.04	0.63	0.63	0.86	0.31	0.00	0.16	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.25	7.85	7.55	3.52	5.13	2.82	0.60	1.61	1.01	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.20	2.28	1.59	1.59	1.59	0.46	0.68	0.23	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	1.21	1.81	0.00	0.00	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	40.80	6.09	7.42	3.18	5.03	6.62	2.65	0.79	1.85	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	36.89	4.66	5.19	1.86	8.12	3.73	3.60	1.73	1.20	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.78	2.63	1.88	1.38	1.38	1.13	0.50	0.75	0.63	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.44	1.01	1.01	1.27	2.28	0.51	0.25	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.04	3.47	3.02	1.81	4.07	1.96	1.51	0.90	0.45	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	1.50	0.75	0.75	4.50	0.00	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	5.17	6.46	1.29	3.88	0.00	3.88	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	4.65	4.65	0.47	0.00	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	3.03	2.02	1.51	1.51	1.01	0.00	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	2.51	2.19	0.63	2.51	1.25	0.00	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.06	0.29	0.59	0.88	0.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	56.57	7.91	4.92	3.25	2.33	4.50	2.75	0.50	0.83	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	0.47	0.47	0.00	0.00	0.93	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.15	3.74	1.87	0.72	3.31	1.58	1.58	0.86	0.86	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.91	1.78	1.53	1.27	2.04	1.53	1.27	0.76	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	15.23	2.07	0.75	1.50	0.75	3.01	2.07	0.56	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.83	7.69	6.01	4.61	5.45	3.91	3.77	0.42	1.26	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.01	2.51	2.43	1.51	1.17	1.09	0.75	0.25	0.42	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	0.95	0.95	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	3.67	1.22	0.73	1.96	1.47	2.20	0.49	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.28	8.18	6.41	2.21	17.45	6.19	9.50	7.95	2.65	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.91	8.78	3.51	2.93	9.36	4.68	7.90	1.76	0.88	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.24	3.30	1.75	0.78	2.14	1.55	0.39	0.19	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.75	2.12	1.06	1.06	1.85	0.26	0.53	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	3.72	1.12	0.37	7.44	0.37	0.00	0.37	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	2.16	0.72	0.72	5.03	0.36	0.72	0.72	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	19.02	4.26	1.70	0.57	3.69	1.14	1.14	1.99	0.28	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.57	3.94	2.36	1.97	4.33	0.79	1.97	0.79	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	10.16	3.30	1.52	1.02	4.57	0.25	0.76	0.00	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	19.57	3.19	1.20	1.20	2.80	0.40	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	2.51	1.67	0.00	1.25	0.00	0.42	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	10.08	0.46	0.46	0.92	1.83	1.38	0.46	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	22.39	5.55	4.04	1.51	3.87	1.68	1.85	2.69	0.84	1.85
Synoviocyte, donor2	11368-117I9	8.72	1.68	3.02	1.17	0.17	1.51	0.17	0.34	0.17	0.00
Synoviocyte, donor3	11440-118H9	8.49	0.89	2.23	0.89	0.67	1.79	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	7.50	1.43	0.71	1.79	0.00	1.43	0.71	0.00	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	0.00	0.00	0.00	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.17	0.46	0.23	0.00	0.23	0.69	0.00	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	16.70	1.94	2.08	1.08	0.65	0.86	0.36	0.14	0.36	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	5.80	1.93	0.39	0.39	0.77	1.16	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	0.00	0.57	1.15	0.57	0.00	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	108.88	9.60	5.41	3.08	8.86	4.80	4.67	1.48	1.85	1.85
Urethra, donor2	10319-105A4	57.55	7.19	3.60	5.40	3.60	8.99	3.60	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	13.02	1.59	1.06	0.00	2.66	1.33	0.80	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	10.01	0.80	0.80	0.80	1.60	0.00	1.20	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.84	0.92	1.38	0.92	0.69	0.23	0.46	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	76.68	13.37	5.35	1.34	8.02	3.79	4.90	2.67	2.23	2.01
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.91	3.56	7.12	3.56	1.78	3.56	0.00	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	2.86	8.58	8.58	4.29	7.15	0.00	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.90	6.16	6.85	4.11	0.00	2.74	1.37	0.00	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.28	3.44	8.95	3.44	1.72	3.79	0.00	0.00	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	26.15	5.23	4.65	1.74	0.58	2.32	0.00	0.58	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	20.82	1.04	8.33	2.08	0.00	5.21	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	17.44	0.00	6.42	5.51	4.59	7.34	0.00	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	2.74	5.48	3.65	0.00	0.91	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.12	0.12	0.00	0.49	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	15.84	0.00	0.88	5.28	0.00	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	79.88	22.90	10.61	12.01	11.17	11.73	1.40	2.23	2.51	1.40
achilles tendon, donor2	10292-104G4	35.13	4.13	4.13	4.13	6.20	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	8.41	3.57	4.84	2.55	0.00	3.31	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	20.20	1.86	1.86	0.93	0.70	1.63	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.08	4.51	13.06	6.05	1.66	8.19	0.00	0.24	0.71	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.97	2.45	8.98	4.63	0.82	3.81	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	27.27	4.78	4.22	2.25	0.84	4.78	0.28	1.12	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	17.98	2.33	3.38	3.38	2.54	2.54	0.42	0.63	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.27	7.08	4.36	5.44	4.63	7.35	0.82	2.18	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.66	2.64	4.85	3.08	2.64	5.29	1.32	1.32	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	34.71	2.86	2.04	2.45	2.04	3.27	0.41	0.82	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	19.41	2.33	1.94	1.55	1.16	2.33	1.55	0.78	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.25	1.10	1.29	3.31	0.55	1.84	0.00	0.37	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	7.80	19.50	3.90	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.68	0.93	2.56	1.63	0.93	2.32	0.70	1.39	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.61	3.37	3.37	2.85	0.52	3.11	0.52	1.04	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	26.30	4.68	3.21	2.05	1.46	2.34	0.58	0.00	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.31	1.39	0.93	1.86	0.93	2.79	0.46	1.86	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	6.99	2.06	0.82	1.23	1.23	0.41	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	21.79	1.84	3.07	4.91	0.92	4.60	0.31	1.23	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	26.88	3.84	2.99	4.69	2.56	2.13	0.00	0.00	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.33	3.03	3.03	3.34	3.03	5.46	0.00	1.82	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.64	5.05	6.74	5.05	1.93	5.05	0.24	0.96	1.20	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.13	0.67	0.45	1.11	0.45	0.67	0.00	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	9.34	6.00	6.00	7.67	0.67	5.00	2.00	0.67	1.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	1.86	0.00	1.86	0.00	0.00	3.72	3.72	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	32.77	4.14	2.26	3.39	1.13	4.52	2.26	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	49.72	2.62	2.18	3.93	3.05	3.93	1.31	1.31	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	74.98	0.00	0.00	7.50	1.87	1.87	18.74	13.12	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.50	4.47	4.24	2.83	4.71	2.35	0.71	3.06	1.88	0.24
adipose tissue, adult, pool1	10010-101C1	33.66	4.03	3.88	1.40	1.55	1.86	0.31	0.62	0.31	0.47
adipose, donor1	10184-103D4	5.28	0.00	0.59	2.93	0.00	1.76	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	4.06	0.81	2.03	11.76	0.00	3.24	0.00	0.00	0.81	0.41
adipose, donor3	10186-103D6	7.62	1.09	0.54	8.71	1.36	3.00	1.09	0.82	0.00	1.91
adipose, donor4	10187-103D7	6.93	0.00	0.00	4.33	0.00	1.73	0.00	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	4.73	0.32	1.58	5.05	0.00	3.79	0.16	0.00	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	14.54	1.73	2.13	2.00	1.07	1.60	0.13	0.40	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.15	1.43	1.43	0.00	0.00	1.43	0.00	0.36	0.36	0.71
amniotic membrane cells, donor1	12235-129G3	188.73	17.16	7.19	3.94	35.01	7.19	17.62	9.27	3.48	4.87
amniotic membrane cells, donor2	12236-129G4	132.54	15.55	5.07	5.07	33.47	5.07	19.61	8.11	1.69	8.11
amniotic membrane cells, donor3	12237-129G5	175.29	20.03	6.48	7.37	35.65	7.66	15.02	7.07	2.65	8.54
amygdala - adult, donor10196	10167-103B5	8.30	4.74	4.74	16.60	0.00	7.11	2.37	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	47.65	13.99	18.45	22.30	5.27	13.18	2.84	1.62	1.82	1.42
amygdala, newborn, donor10223	10360-105E9	16.14	5.16	1.61	4.20	6.13	0.97	0.65	0.65	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	44.95	7.00	4.33	2.80	2.42	5.09	0.51	0.51	2.29	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.22	2.65	4.41	2.87	0.44	3.53	0.00	0.44	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	126.27	34.41	17.37	28.73	12.03	27.39	41.09	5.68	8.02	20.71
aorta, adult, pool1	10052-101G7	36.87	5.10	3.53	5.30	1.96	4.12	0.78	0.39	0.78	0.39
appendix, adult	10189-103D9	39.59	4.66	7.76	4.66	3.10	3.10	1.16	1.94	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.16	6.88	2.41	2.41	0.00	1.72	1.72	0.34	1.03	0.34
artery, adult	10190-103E1	33.97	1.36	2.72	2.72	4.08	6.79	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	22.31	3.91	3.04	1.01	2.32	0.87	0.72	0.00	1.30	0.29
b cell line:RPMI1788	10427-106D4	5.50	1.64	2.08	4.91	0.15	2.83	0.00	0.00	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.31	4.99	3.61	1.39	2.22	1.94	1.11	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.67	12.90	4.76	4.17	11.51	3.67	2.78	2.68	2.28	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	18.91	3.01	3.51	2.68	1.67	2.01	0.67	0.00	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	28.52	1.68	2.24	1.12	1.12	4.47	0.56	0.56	1.12	0.00
bladder, adult, pool1	10011-101C2	35.96	4.45	6.52	4.35	1.09	3.37	0.76	0.33	0.76	0.11
blood, adult, pool1	10053-101G8	19.93	2.21	8.86	0.00	2.21	8.86	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	21.41	2.57	1.71	0.00	1.71	2.57	0.86	0.86	0.86	0.00
bone marrow, adult	10192-103E3	16.87	0.67	2.02	0.67	1.35	1.35	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	20.50	4.10	6.15	10.25	0.00	6.15	2.05	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	24.72	9.58	9.91	7.68	2.67	5.46	0.56	0.11	0.78	0.22
brain, fetal, pool1	10085-102B4	5.34	2.67	0.00	2.67	0.00	2.67	0.00	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	12.88	1.65	1.32	3.30	0.99	0.99	0.00	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	20.35	3.87	4.74	5.99	3.12	3.87	0.12	0.12	1.12	0.12
breast, adult, donor1	10080-102A8	50.51	2.53	2.53	3.79	1.26	6.31	1.89	0.00	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.53	1.02	1.91	1.02	0.76	1.91	0.51	1.14	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	3.71	1.86	4.02	3.71	2.47	0.00	1.55	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	54.10	8.75	2.99	1.61	12.66	1.15	1.38	3.22	1.38	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.28	1.69	2.18	2.66	3.63	2.18	0.48	1.45	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	4.23	2.35	3.29	4.23	0.00	2.82	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	80.39	19.80	7.33	8.86	8.09	11.59	10.61	2.08	4.16	5.25
carcinoid cell line:SK-PN-DW	10719-109I8	7.61	0.63	5.07	9.51	0.32	6.97	0.00	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	13.31	1.33	3.46	3.19	0.00	4.53	0.80	0.27	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	21.88	9.21	4.61	9.21	8.06	11.51	1.15	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	22.92	6.53	11.55	16.06	1.67	11.21	1.67	0.50	1.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	21.40	6.88	6.88	9.93	1.53	1.53	3.06	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.02	4.03	1.46	4.39	4.03	2.56	1.10	1.46	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	20.39	14.57	17.48	72.83	17.48	23.31	0.00	0.00	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	35.23	15.59	40.35	54.45	14.09	31.39	1.28	0.43	1.71	0.85
cerebellum, adult, pool1	10083-102B2	12.76	5.86	14.49	25.18	1.03	10.35	0.34	1.03	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	11.62	4.98	2.49	25.74	13.28	7.47	0.00	2.49	1.66	0.83
cerebral meninges, adult	10188-103D8	30.00	6.05	5.55	8.32	3.53	4.29	1.51	1.26	2.27	1.01
cerebrospinal fluid, donor2	10294-104G6	18.27	6.58	4.39	4.39	0.73	3.65	1.46	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	29.62	2.44	2.01	0.86	5.61	2.16	0.58	0.43	0.43	0.29
cervical cancer cell line:ME-180	10553-107I4	29.00	6.96	4.31	2.15	12.43	2.15	0.50	1.66	1.82	0.17
cervix, adult, pool1	10013-101C4	46.30	7.77	9.13	4.20	3.15	3.88	1.99	1.68	0.73	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	13.52	2.51	1.67	1.95	0.14	0.98	0.00	0.00	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	44.41	2.61	0.00	1.31	1.31	2.61	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	15.78	0.87	1.62	1.74	0.50	0.50	0.00	0.12	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	1.23	0.25	0.25	0.00	0.12	0.37	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	13.04	0.47	0.71	1.66	0.95	1.19	0.00	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	79.49	5.98	3.70	1.42	18.23	3.42	7.98	3.42	0.57	2.56
chorionic membrane cells, donor2	12239-129G7	143.78	14.72	6.07	3.48	23.96	6.86	26.25	7.46	3.88	6.96
chorionic membrane cells, donor3	12240-129G8	100.01	3.85	3.85	3.30	28.57	1.10	6.59	7.14	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	2.02	1.01	3.03	0.00	4.04	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.71	0.96	2.50	2.69	0.96	1.73	0.38	0.38	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	33.37	0.84	2.11	3.80	2.11	1.90	1.48	1.06	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	19.77	0.77	2.57	2.05	0.26	2.57	0.51	0.26	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	23.22	4.35	4.84	2.18	0.24	2.90	0.48	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	21.79	2.65	4.48	2.65	0.41	1.63	0.00	0.00	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	27.09	3.83	6.77	4.71	0.88	2.06	0.29	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.70	5.99	7.30	4.17	2.61	3.65	1.56	1.30	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.23	0.69	0.91	0.69	0.00	1.60	0.00	0.69	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	30.02	7.11	4.68	1.39	9.02	2.43	2.95	1.91	1.21	0.52
colon carcinoma cell line:CACO-2	10513-107D9	15.92	2.56	2.38	1.10	1.65	1.65	1.65	0.18	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	33.83	6.84	5.32	2.28	3.04	4.18	0.76	1.14	0.76	0.00
colon, adult, donor1	10082-102B1	61.88	3.57	4.76	1.19	2.38	0.00	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	68.50	5.52	5.64	2.12	4.94	2.59	1.41	1.18	1.06	0.35
colon, fetal, donor1	10070-101I7	91.46	6.18	6.80	3.71	1.24	2.47	1.85	2.47	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	183.34	27.50	22.92	22.92	4.58	4.58	0.00	9.17	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	46.74	11.47	6.80	1.27	4.25	3.82	1.27	3.40	2.12	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	35.47	5.74	2.72	1.21	5.43	2.11	0.91	3.47	0.75	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	42.30	6.63	4.79	3.10	6.63	1.13	1.69	1.97	0.85	0.99
corpus callosum, adult, pool1	10042-101F6	65.34	31.29	21.67	10.28	9.40	10.39	2.32	1.44	4.31	1.00
cruciate ligament, donor2	10295-104G7	36.47	4.05	4.05	3.24	4.86	2.43	2.43	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	2.41	2.41	4.01	2.41	5.62	4.01	1.61	0.80	1.61
diencephalon, adult	10193-103E4	23.04	10.08	7.92	7.92	4.32	8.40	1.20	1.20	2.16	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	3.44	1.84	1.38	2.30	0.23	1.84	0.00	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.52	4.87	3.08	0.77	5.13	1.03	0.00	0.26	1.80	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.37	2.17	1.93	1.44	1.20	0.72	1.44	0.48	0.48	0.00
ductus deferens, adult	10196-103E7	31.89	4.49	2.99	1.99	1.50	1.99	0.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	7.20	0.00	1.44	0.00	4.32	1.44	0.00	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.82	16.92	7.36	4.41	5.15	5.15	3.68	2.94	0.74	5.15
dura mater, adult, donor1	10041-101F5	38.57	5.78	5.62	3.30	2.06	3.30	1.07	0.66	0.91	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.20	7.99	1.11	2.00	3.78	1.78	1.33	1.11	3.55	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.64	4.59	1.15	2.29	1.58	2.44	1.15	0.14	0.86	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	54.26	6.17	3.70	3.70	6.17	1.85	0.62	1.85	0.00	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	38.44	7.57	3.63	1.21	4.84	2.12	1.82	1.21	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.57	5.87	2.47	2.16	3.40	0.31	2.78	1.54	0.93	1.85
embryonic pancreas cell line:2C6	10603-108E9	61.73	10.51	1.31	0.00	5.25	5.25	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	46.59	2.68	2.01	2.35	1.01	1.34	2.35	0.67	1.01	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.77	5.07	6.16	3.44	4.17	2.36	2.72	1.27	0.91	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.05	3.54	4.34	2.73	2.41	1.77	0.80	1.61	1.13	0.16
epidermoid carcinoma cell line:A431	10426-106D3	39.79	4.78	2.22	1.56	5.56	2.22	1.45	1.00	1.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	45.64	16.83	6.16	5.50	8.25	6.16	1.43	1.87	3.08	1.43
epididymis, adult	10197-103E8	21.56	3.35	3.35	2.30	1.05	1.67	0.42	0.42	1.26	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.24	2.31	3.19	1.95	2.84	1.95	1.60	0.71	1.24	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	69.21	3.54	2.36	1.18	4.72	1.97	8.26	2.75	1.97	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.30	5.64	2.10	3.15	12.84	4.59	5.37	2.36	2.36	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	58.46	6.50	3.15	2.76	18.80	4.92	4.63	3.25	3.35	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.41	6.39	2.80	2.58	12.77	4.03	5.49	4.26	2.35	1.46
esophagus, adult, pool1	10015-101C6	33.02	3.19	3.93	2.87	1.17	2.23	0.85	0.42	0.53	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.76	0.25	2.76	6.14	0.00	3.38	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	9.66	19.32	2.41	7.24	0.00	2.41	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	37.88	0.00	4.21	14.73	8.42	10.52	6.31	8.42	0.00	4.21
eye - muscle medial, donor2	10299-104H2	58.04	1.49	7.44	17.86	10.42	11.91	1.49	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	32.10	2.29	4.59	10.32	4.59	5.73	3.44	1.15	2.29	3.44
eye - vitreous humor, donor1	10268-104D7	21.86	4.37	1.46	2.91	0.00	4.37	2.91	1.46	1.46	2.91
eye, fetal, donor1	10054-101G9	23.64	6.10	6.86	6.86	1.27	3.31	1.27	0.25	0.51	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	34.62	4.49	2.44	2.56	2.18	3.33	2.56	0.38	0.90	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	51.28	5.70	5.22	3.56	3.09	3.56	1.90	0.95	1.42	0.71
frontal lobe, adult, pool1	10040-101F4	23.17	7.41	10.88	9.48	2.44	5.54	0.66	0.38	1.69	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	76.86	11.11	5.40	4.80	10.21	4.80	9.61	4.20	3.30	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.53	2.74	2.10	0.82	0.55	0.64	0.09	0.18	0.37	0.00
gall bladder, adult	10198-103E9	46.84	7.00	4.83	2.41	3.86	1.93	1.21	2.66	1.93	0.72
gamma delta positive T cells, donor1	11937-126A2	3.22	1.07	8.59	5.37	0.00	3.76	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	7.10	1.49	7.10	4.11	0.37	2.24	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.53	2.75	1.27	1.90	4.01	0.84	0.63	1.06	1.06	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	82.59	4.06	3.29	1.74	13.35	2.32	11.02	5.03	2.32	3.87
gastric cancer cell line:AZ521	10549-107H9	4.43	0.16	0.98	0.82	0.33	0.49	0.00	0.33	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	19.22	4.58	4.58	4.58	0.00	1.83	0.92	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.91	6.63	4.80	2.06	0.46	2.97	0.46	0.46	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	14.80	5.74	4.82	0.80	2.75	1.84	0.46	0.46	0.92	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	32.89	3.64	1.96	2.52	4.90	1.54	1.12	0.42	0.70	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	64.10	8.23	2.74	3.49	7.73	3.49	1.75	2.24	2.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	139.65	14.25	7.18	6.02	22.17	6.65	14.14	5.49	3.48	11.40
glioblastoma cell line:A172, tech_rep2	10444-106F3	154.48	12.78	5.76	5.06	22.75	5.90	20.36	5.20	3.65	12.92
glioblastoma cell line:T98G	10485-107A8	78.03	6.73	1.99	1.43	11.59	4.64	3.75	1.43	1.21	1.66
glioma cell line:GI-1	10413-106B8	16.69	1.17	0.59	1.46	1.76	1.46	0.00	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	37.17	10.20	8.02	13.12	10.93	10.20	1.46	1.46	2.19	0.73
globus pallidus, adult, donor10252	10161-103A8	82.75	31.24	27.34	15.38	6.35	20.75	2.20	0.98	3.42	0.24
globus pallidus, adult, donor10258	10367-105F7	30.12	16.43	0.00	20.54	10.95	10.95	2.74	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	16.52	4.26	6.93	4.26	4.26	0.00	1.07	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	195.77	22.02	14.68	4.89	31.81	9.79	4.89	14.68	9.79	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	36.16	13.12	7.68	3.52	2.88	4.16	2.56	1.92	1.28	2.56
hIPS +CCl2, biol_rep1	14383-156B9	0.92	0.92	0.00	0.46	0.00	0.46	0.46	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	1.37	0.00	0.00	1.37	0.46	1.37	1.37	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	1.93	0.00	0.00	1.29	0.64	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	1.44	0.00	0.00	2.87	1.44	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	0.00	0.00	0.69	2.06	1.37	0.00	0.00	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	8.83	5.52	4.41	6.62	8.83	11.03	3.31	2.21	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	3.45	0.86	2.87	6.32	0.00	4.31	0.29	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	48.13	7.77	4.19	5.08	4.48	5.38	2.99	1.79	0.60	4.19
heart - pulmonic valve, adult	10206-103F8	39.22	6.28	4.18	4.97	2.88	2.61	0.26	0.52	0.78	1.31
heart - tricuspid valve, adult	10207-103F9	46.63	5.83	7.49	3.33	3.33	6.66	0.83	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	17.75	2.65	3.47	2.04	0.61	1.84	0.61	0.00	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	14.90	1.70	5.11	3.41	0.85	2.98	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	34.73	4.83	5.98	4.14	3.22	3.45	0.23	0.46	0.92	0.00
heart, fetal, pool1	10046-101G1	39.94	9.14	11.19	6.06	1.85	6.26	1.33	0.82	1.13	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	42.88	2.47	3.39	4.32	5.55	3.39	2.47	2.16	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	123.67	1.19	2.38	5.95	5.95	2.38	34.49	1.19	1.19	15.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.39	2.76	4.64	1.10	0.33	2.54	1.99	0.44	0.33	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.43	2.55	3.16	2.31	0.61	1.82	2.06	0.49	0.24	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	28.50	3.54	3.94	1.92	0.51	2.02	2.63	0.20	0.20	0.91
hepatoma cell line:Li-7	10484-107A7	31.81	2.89	1.45	0.67	5.12	1.33	1.33	0.56	1.11	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.56	2.41	3.02	3.52	0.80	3.52	0.70	0.10	0.60	0.10
hippocampus - adult, donor10196	10169-103B7	25.55	4.73	9.46	20.82	1.89	10.41	1.89	0.95	1.89	1.89
hippocampus, adult, donor10252	10153-102I9	46.94	17.55	20.00	18.57	5.51	16.74	2.45	2.04	1.02	0.41
hippocampus, adult, donor10258	10374-105G5	9.46	3.98	5.98	16.43	1.99	3.98	0.50	2.49	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	14.10	3.17	1.76	9.52	3.88	3.88	0.00	0.35	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.22	0.61	1.22	0.00	0.61	1.22	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1.18	0.00	0.59	0.79	0.00	0.79	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.54	0.00	0.00	0.51	0.25	0.51	0.25	0.25	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	0.56	1.13	3.95	0.00	1.13	0.00	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.65	0.52	0.26	2.84	0.26	0.52	0.52	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.80	0.38	0.38	3.04	0.00	0.76	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	13.43	2.34	1.17	3.50	0.88	1.75	1.46	0.88	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	13.14	1.94	1.72	5.39	0.86	1.94	2.15	0.43	0.43	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	14.18	1.25	1.67	3.75	0.42	0.83	1.67	0.42	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.26	1.18	2.84	5.92	4.50	1.42	2.37	1.89	0.47	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.16	1.61	1.93	6.27	1.13	1.93	1.93	1.13	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	2.02	2.02	5.39	2.02	1.35	0.00	0.67	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.50	0.31	0.16	0.47	0.00	0.31	0.31	0.00	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	0.00	0.49	0.98	0.00	0.49	0.00	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.87	0.00	0.00	0.00	0.87	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	6.30	0.38	1.91	5.35	0.00	2.29	0.00	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	4.80	0.87	2.18	6.11	0.44	2.18	0.00	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5.50	0.00	1.50	8.50	0.00	1.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.52	0.94	2.26	9.80	0.57	3.20	0.19	0.00	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.91	0.91	2.27	11.37	0.00	3.18	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.95	0.63	2.19	9.08	0.31	2.82	0.00	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.72	1.31	3.76	9.47	0.33	3.43	0.33	0.16	0.16	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2.61	1.16	2.32	9.00	0.29	4.35	0.29	0.00	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.48	1.49	2.39	10.16	0.30	2.69	0.30	0.00	0.90	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1.85	0.55	0.55	0.92	0.18	1.11	0.00	0.18	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	2.57	0.00	0.57	1.43	0.00	0.57	0.29	0.00	0.29	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2.45	2.04	0.00	1.22	1.22	0.82	0.00	0.00	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.82	0.70	0.00	3.17	0.70	0.70	0.35	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	0.00	1.58	4.75	0.32	1.27	0.00	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.26	0.61	0.91	3.93	0.30	0.30	0.30	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.31	1.03	1.03	11.89	0.52	1.55	0.00	0.52	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	0.66	3.98	8.63	0.66	2.66	0.66	0.00	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.72	1.03	1.54	4.10	0.77	2.05	1.03	0.51	0.77	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.93	1.79	1.28	10.99	2.30	1.79	1.53	1.02	0.77	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	4.54	0.76	3.03	9.84	1.51	2.27	0.76	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.07	1.34	2.02	3.36	0.67	3.36	1.01	1.01	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.72	0.97	0.24	1.69	0.00	0.00	0.00	0.00	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2.23	0.89	0.00	0.00	0.00	0.89	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	2.44	0.49	0.00	0.49	0.00	0.98	1.46	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.81	0.92	0.31	3.67	0.00	0.61	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	0.00	0.00	0.00	3.25	6.51	3.25	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.29	0.33	1.32	1.65	0.33	0.99	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.21	0.55	1.09	3.28	0.00	3.28	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.58	1.09	0.72	5.43	0.72	1.81	0.72	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	11.74	0.00	0.36	6.41	0.00	1.07	0.71	0.71	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	0.00	1.19	8.35	0.00	1.19	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	7.58	1.49	2.44	7.18	0.68	1.63	0.95	0.81	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.39	0.81	0.00	5.39	1.35	1.08	0.27	0.00	0.00	1.08
immature langerhans cells, donor1	11904-125F5	25.91	4.12	3.63	1.45	15.26	2.91	2.18	5.57	3.39	1.21
immature langerhans cells, donor2	11905-125F6	118.03	10.30	3.96	5.54	26.93	2.38	13.47	13.47	4.75	7.92
insula, adult, pool1	10039-101F3	23.37	6.91	8.71	8.80	1.80	6.15	1.32	0.28	1.04	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	15.61	1.30	0.98	1.63	0.98	0.65	0.00	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	47.86	4.91	4.91	2.70	3.30	2.20	1.30	0.70	0.70	0.50
kidney, fetal, pool1	10045-101F9	43.93	9.48	6.22	3.82	2.76	4.60	4.53	0.71	1.63	4.17
large cell lung carcinoma cell line:IA-LM	10509-107D5	28.40	3.55	3.27	1.99	2.41	3.27	0.99	0.57	0.28	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.95	4.29	1.80	0.28	2.76	1.24	0.69	0.69	0.97	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.66	11.19	4.95	3.67	7.34	5.32	1.47	1.47	4.04	0.73
left atrium, adult, donor1	10079-102A7	17.98	3.27	0.54	2.72	0.00	5.45	1.09	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	15.68	2.53	3.54	3.54	0.00	2.53	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.82	0.00	0.55	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	17.96	4.31	2.16	3.23	3.23	1.08	1.44	0.72	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	15.76	2.17	2.17	1.09	3.80	1.63	0.00	2.17	0.54	0.54
leiomyoma cell line:15425	10571-108B4	25.25	6.56	2.19	2.43	4.86	1.94	2.43	2.43	1.21	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	2.09	2.09	0.00	1.05	4.18	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	18.65	4.96	3.66	3.90	2.95	3.54	0.47	0.83	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	25.15	4.06	1.09	1.09	3.59	2.34	2.50	1.09	0.78	1.25
liposarcoma cell line:SW 872	10726-110A6	41.43	4.02	3.17	2.68	7.92	3.17	4.39	1.83	0.61	1.71
liver, adult, pool1	10018-101C9	48.29	3.57	2.43	1.94	2.27	2.27	0.49	1.13	0.49	0.00
liver, fetal, pool1	10086-102B5	25.40	2.82	2.82	1.88	0.94	0.94	1.88	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	71.45	15.60	12.69	15.89	6.27	7.73	2.33	1.46	3.06	0.44
locus coeruleus, adult, donor10252	10165-103B3	53.15	19.01	14.58	11.63	6.83	14.21	2.77	1.29	3.32	0.55
locus coeruleus, adult, donor10258	10375-105G6	22.57	8.18	9.31	21.44	5.08	12.13	1.97	1.13	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	15.56	9.67	5.89	2.94	7.57	2.52	1.26	1.26	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	20.21	1.94	1.66	1.11	0.69	0.28	0.28	0.42	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	130.30	7.58	1.38	3.45	27.58	2.76	5.52	2.76	2.07	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	46.00	4.48	3.43	2.90	2.64	1.98	0.79	1.05	0.66	0.53
lung, adult, pool1	10019-101D1	77.02	12.40	7.21	4.73	5.43	5.32	1.77	1.18	1.77	0.35
lung, fetal, donor1	10068-101I5	68.78	8.28	10.56	3.71	4.00	8.28	8.28	2.00	0.86	2.28
lung, right lower lobe, adult, donor1	10075-102A3	66.90	12.83	10.08	5.50	5.04	7.33	3.67	3.67	1.37	3.21
lymph node, adult, donor1	10077-102A5	21.77	3.79	5.21	3.79	0.95	3.31	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	14.68	0.22	1.53	1.97	0.66	1.32	0.44	0.22	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.94	3.32	2.72	2.57	0.45	2.11	0.15	0.15	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	10.19	4.25	1.70	10.19	0.85	1.70	4.25	4.25	0.00
mature adipocyte, donor1	12231-129F8	51.95	1.78	3.11	2.66	2.66	0.89	0.00	0.00	0.89	0.00
mature adipocyte, donor2	12232-129F9	46.28	2.28	3.94	1.04	3.74	1.87	0.83	0.83	0.00	0.00
mature adipocyte, donor3	12233-129G1	35.80	0.95	1.42	0.24	2.13	0.71	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	52.91	2.37	2.63	1.05	1.84	0.53	1.58	0.26	0.79	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	47.18	4.05	4.77	2.62	1.67	3.57	0.71	0.71	1.43	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	0.00	11.28	11.28	1.13	7.90	0.00	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.92	10.85	20.05	12.51	3.31	9.93	1.29	1.10	1.29	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	11.12	1.59	8.58	11.12	1.59	4.45	1.27	0.64	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	5.97	6.40	0.85	3.41	7.25	2.99	0.00	2.13	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	24.47	5.23	10.13	14.01	2.36	3.88	0.17	0.84	1.35	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	31.20	11.04	16.13	18.25	3.82	15.92	1.27	1.27	1.06	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	5.78	17.34	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	0.00	28.71	0.00	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.97	2.51	1.44	5.38	4.31	1.44	0.00	1.79	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	36.34	10.38	6.49	14.28	7.14	6.49	2.60	1.30	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	52.79	21.83	22.29	13.93	10.06	15.48	2.32	2.17	4.49	1.24
medulla oblongata, adult, pool1	10038-101F2	42.36	16.49	13.71	9.55	5.88	7.43	2.29	1.31	1.71	0.90
medulla oblongata, newborn, donor10223	10361-105F1	22.57	6.25	6.60	5.21	3.82	3.12	1.04	1.04	1.39	1.04
medulloblastoma cell line:D283 Med	10838-111E1	15.28	1.33	4.87	5.31	1.11	6.20	0.44	0.66	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	31.06	3.79	3.06	4.65	1.83	4.04	1.59	0.98	0.49	0.98
melanoma cell line:COLO 679	10514-107E1	29.90	3.74	1.87	0.72	3.59	0.72	1.58	1.01	0.72	0.00
melanoma cell line:G-361	10465-106H6	22.26	1.36	0.81	0.54	3.26	1.90	0.27	0.00	1.63	0.81
meningioma cell line:HKBMM	10691-109F7	23.34	3.80	2.35	0.72	1.45	2.71	1.81	0.72	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	5.29	0.88	0.88	1.76	0.00	0.88	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	7.26	1.81	2.07	4.93	0.52	2.07	0.26	0.00	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	16.11	0.92	0.77	0.92	1.07	1.38	0.31	0.61	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.91	0.91	0.73	0.18	0.73	0.36	0.00	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.28	0.83	0.41	1.24	1.24	0.83	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	14.05	1.40	1.26	0.42	0.42	1.26	0.28	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.60	2.12	2.50	0.58	1.16	1.54	0.39	0.39	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.72	0.00	0.69	1.39	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.76	2.23	1.03	0.69	1.72	0.69	0.51	0.34	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.80	2.19	3.11	0.69	1.27	0.58	0.35	0.12	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	15.92	0.93	1.59	1.59	1.46	0.93	0.40	0.27	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.12	2.57	1.35	0.54	2.03	0.81	0.54	0.27	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.15	3.56	1.42	1.28	4.41	2.56	1.85	0.85	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.55	1.32	0.99	0.33	0.00	0.66	0.33	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.11	1.66	1.52	1.38	2.35	1.66	0.83	0.69	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.90	5.24	1.40	1.40	1.05	0.70	1.40	1.40	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	30.62	5.92	2.86	0.82	3.88	3.67	3.27	1.84	1.84	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	27.32	3.24	3.24	2.52	6.83	2.52	3.95	4.31	1.80	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.48	1.55	1.55	0.41	0.00	0.72	0.21	0.10	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.68	2.05	1.14	0.23	0.46	0.91	0.46	0.68	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	19.30	6.29	2.52	0.84	1.26	3.78	1.68	2.10	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	27.20	4.63	1.64	0.90	4.63	2.39	1.20	1.20	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.29	2.54	1.49	1.05	1.23	0.70	0.35	0.18	0.96	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.99	2.95	1.10	2.58	0.74	0.37	0.37	0.74	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	31.48	7.73	3.43	2.29	5.44	2.29	0.29	2.58	1.72	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	1.68	5.05	1.26	1.68	1.68	0.00	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	0.46	2.28	2.28	1.37	0.91	0.46	0.91	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.67	1.02	1.02	1.79	1.28	1.02	1.02	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.16	0.26	2.36	2.09	1.83	0.79	0.26	0.26	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.17	1.23	0.31	1.23	0.62	0.00	0.92	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.65	1.18	0.71	1.18	0.24	0.71	0.00	0.00	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.14	0.34	0.34	1.35	0.00	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	5.11	0.00	2.75	1.96	0.39	0.00	0.39	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.88	1.39	0.46	0.93	1.85	0.93	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	8.08	1.44	1.15	0.58	0.29	0.29	0.58	0.29	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.14	1.34	0.22	0.45	1.56	1.78	0.45	0.22	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.17	1.20	0.72	3.12	1.68	0.72	0.24	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	1.47	0.73	0.00	1.47	0.73	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.38	0.34	1.34	1.68	0.34	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	0.41	0.41	0.41	0.41	0.82	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	7.73	2.15	0.43	2.15	0.43	0.00	0.00	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	2.73	0.00	2.73	5.47	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.85	0.32	0.97	2.27	0.32	0.97	0.00	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	1.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	1.07	2.13	1.07	1.07	0.00	0.53	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	0.00	0.82	0.82	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	2.72	0.78	0.78	0.39	0.78	0.78	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	0.00	0.00	4.20	2.10	2.10	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	0.99	0.00	1.99	0.00	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	1.19	0.59	1.78	0.00	1.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	0.00	2.44	0.00	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	11.40	0.63	2.53	3.17	1.27	0.63	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	1.03	1.38	1.38	3.79	0.00	0.34	1.03	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	4.30	0.00	0.00	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	0.00	0.81	1.63	4.48	0.41	1.22	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	1.59	0.79	0.79	4.77	2.38	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	0.59	1.18	0.00	5.90	0.59	2.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.78	0.62	0.31	0.62	2.81	0.62	0.31	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	4.01	0.00	0.00	1.34	0.00	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	1.18	1.18	0.00	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	2.57	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	0.00	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	1.48	0.49	0.49	0.00	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	0.00	0.00	0.00	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.88	0.00	0.00	0.81	1.21	0.00	0.81	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	0.00	0.00	0.00	2.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	1.82	0.00	0.61	0.61	0.00	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	0.00	0.00	0.00	1.65	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.50	0.40	0.79	0.20	0.40	0.20	0.20	0.40	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.38	0.00	0.97	0.65	0.65	0.97	0.00	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	1.02	1.02	1.02	0.00	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	56.48	4.64	1.55	0.00	3.87	1.55	3.09	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	62.60	6.61	6.38	4.02	2.83	2.83	1.65	0.71	1.18	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.84	4.63	2.32	1.62	1.39	1.85	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	16.13	2.67	1.75	0.72	2.16	0.21	0.41	0.72	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	6.58	1.13	0.23	0.23	0.00	1.59	0.00	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	21.02	3.67	2.93	2.44	2.69	1.47	1.22	1.22	0.73	1.71
mesothelioma cell line:Mero-48a	10852-111F6	19.49	3.32	2.66	3.54	3.76	1.11	0.66	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	18.40	2.63	1.58	2.37	0.79	1.31	0.79	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	9.53	1.02	2.55	1.19	2.04	1.19	0.00	0.17	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	11.12	3.03	1.77	1.52	1.01	1.26	0.76	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	14.08	2.28	1.86	0.83	1.45	0.41	0.21	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	19.22	1.99	2.65	2.65	1.66	3.15	0.66	0.83	1.16	0.17
mesothelioma cell line:NCI-H226	10846-111E9	10.14	1.63	0.36	0.18	0.36	1.09	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	13.15	1.37	0.68	1.37	1.20	1.02	0.34	0.17	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	6.11	0.00	2.54	5.85	0.00	1.78	0.00	1.02	0.00	0.00
mesothelioma cell line:No36	10857-111G2	6.20	1.30	1.63	1.63	0.98	0.33	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	19.51	3.25	1.63	1.63	3.25	1.35	0.54	1.63	1.63	0.00
migratory langerhans cells, donor1	11901-125F2	9.21	2.11	2.30	1.34	0.38	0.96	0.19	0.19	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	12.33	2.20	4.03	1.10	0.61	0.98	0.00	0.85	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	8.26	3.05	5.92	3.59	0.90	2.33	0.72	1.44	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.02	2.94	2.29	0.98	0.65	1.63	0.00	0.65	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.33	0.85	1.06	2.33	1.48	0.85	0.00	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	166.09	12.67	5.76	6.91	7.60	7.60	8.29	4.84	2.07	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.85	0.95	1.14	1.52	0.57	0.76	0.38	0.00	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	21.62	2.77	3.51	2.40	0.55	2.03	0.74	0.00	0.55	0.00
myeloma cell line:PCM6	10474-106I6	21.35	0.99	1.19	0.79	0.20	0.59	0.00	0.20	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	67.47	6.59	2.03	3.04	7.10	3.04	1.52	3.04	1.01	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	27.66	1.77	1.37	1.57	5.10	1.96	1.57	0.00	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.17	3.45	3.68	2.45	1.23	3.12	0.56	0.22	1.45	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.43	5.07	3.09	0.96	1.18	1.40	0.22	0.37	0.74	0.15
nasal epithelial cells, donor2	12227-129F4	26.50	1.66	2.76	1.66	3.31	0.00	0.55	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	23.70	2.99	5.52	4.83	1.61	3.91	1.84	0.00	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	13.66	4.12	4.86	2.99	1.31	4.12	0.37	0.56	0.37	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	6.54	4.22	6.54	9.07	2.74	5.69	0.63	0.63	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	5.59	0.37	2.42	3.17	0.19	2.61	0.00	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.95	0.24	1.90	2.85	0.00	2.85	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	79.19	26.13	19.32	20.11	10.61	20.59	25.82	3.80	3.17	10.93
neuroectodermal tumor cell line:TASK1	10774-110F9	12.88	1.01	1.41	3.42	0.00	2.01	0.00	0.00	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	7.63	0.64	1.27	12.08	0.00	7.63	1.91	0.00	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	14.64	0.80	1.60	1.06	0.53	1.86	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	327.25	29.75	14.87	44.62	29.75	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	9.47	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	56.66	3.04	7.61	4.06	0.85	5.58	2.20	0.34	0.51	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	4.80	5.60	0.80	1.60	5.60	0.00	1.60	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.48	0.96	1.60	2.56	2.24	0.96	2.56	1.28	0.64	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	53.87	9.72	3.94	2.89	13.66	5.26	8.67	6.83	1.84	2.63
nucleus accumbens, adult, pool1	10037-101F1	24.47	6.37	10.59	9.00	3.28	6.19	1.50	0.28	1.12	0.09
occipital cortex - adult, donor10196	10172-103C1	12.36	2.06	14.42	16.48	0.00	18.54	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	52.06	18.25	25.49	26.30	6.98	17.98	0.81	0.81	2.42	0.81
occipital cortex, newborn, donor10223	10355-105E4	10.19	1.09	3.28	4.37	2.91	1.46	0.36	0.73	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	26.76	5.25	12.33	15.48	2.36	7.35	1.57	1.84	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	9.01	3.00	4.29	8.58	0.86	3.86	0.43	0.86	0.00	0.43
occipital pole, adult, pool1	10036-101E9	10.01	2.92	5.91	5.44	0.71	3.55	0.16	0.00	0.39	0.32
olfactory region, adult	10195-103E6	25.79	8.60	10.70	15.09	2.87	11.08	0.76	0.96	1.15	0.96
optic nerve, donor1	10277-104E7	52.03	16.01	16.01	30.02	4.00	16.01	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	50.23	11.16	3.87	2.96	19.25	2.85	1.94	4.56	2.39	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	27.75	3.71	6.05	2.61	2.89	2.61	0.96	0.14	0.55	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.83	3.56	1.02	1.19	2.37	0.51	0.34	0.85	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.94	3.47	2.43	2.31	4.50	1.62	0.69	0.46	0.58	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	16.46	1.47	3.23	2.06	0.59	0.88	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	138.28	8.41	3.74	4.67	7.47	1.87	3.74	1.87	2.80	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	7.63	0.85	1.48	1.06	1.06	1.48	0.42	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	15.72	3.49	3.67	2.88	1.05	2.62	0.26	0.17	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.40	1.65	1.65	2.02	0.00	2.20	0.00	0.00	0.18	0.00
pancreas, adult, donor1	10049-101G4	119.46	21.63	7.53	10.35	26.34	12.23	19.75	10.35	2.82	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	10.06	0.28	0.84	0.28	0.84	0.84	0.00	0.00	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	20.44	3.24	0.17	0.68	4.09	0.68	0.34	1.02	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	165.42	29.97	9.27	5.96	18.38	10.43	17.55	5.63	5.96	6.13
paracentral gyrus, adult, pool1	10035-101E8	25.35	6.32	12.45	7.96	2.93	6.04	0.92	0.73	0.73	0.55
parietal cortex, adult, donor10258	10373-105G4	5.14	4.40	8.81	4.40	1.47	4.40	0.73	1.47	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	14.11	0.94	8.46	10.35	0.94	8.46	0.94	0.00	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	23.94	7.98	16.25	12.54	2.85	10.83	0.57	1.14	1.14	1.43
parietal lobe, adult, pool1	10034-101E7	22.65	6.52	10.93	7.58	2.82	5.11	0.35	0.18	1.50	0.35
parietal lobe, fetal, donor1	10072-101I9	10.67	0.00	0.00	4.85	0.97	0.97	0.97	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	9.72	5.61	2.99	5.23	2.62	1.50	0.37	0.37	1.12	0.37
parotid gland, adult	10199-103F1	32.68	7.40	8.02	7.40	28.98	4.93	0.00	3.70	5.55	0.62
penis, adult	10200-103F2	37.06	8.59	10.21	1.61	3.76	3.22	2.15	2.69	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	4.28	2.23	5.21	9.11	0.19	4.46	0.37	0.00	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.11	2.77	2.91	1.17	2.91	1.89	0.73	1.02	1.02	0.15
pineal gland - adult, donor10196	10179-103C8	30.32	11.61	12.26	20.64	1.94	11.61	1.29	1.94	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	35.53	9.48	18.36	14.81	2.96	15.40	1.18	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	26.34	3.76	7.52	15.05	5.64	6.27	2.51	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	18.21	9.11	12.14	9.11	0.00	18.21	1.01	0.00	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	31.79	8.34	23.45	10.94	1.04	12.51	1.04	1.04	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	18.73	1.70	1.70	11.07	4.26	3.40	0.85	0.00	1.70	0.00
placenta, adult, pool1	10021-101D3	122.77	8.92	4.09	3.12	8.06	1.61	5.70	2.04	2.69	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	6.89	1.99	2.38	2.38	0.53	2.38	0.13	0.00	0.40	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	40.78	3.11	3.58	2.02	2.02	2.02	0.62	0.16	0.47	0.00
pons, adult, pool1	10033-101E6	38.39	13.00	11.45	8.86	6.71	4.91	1.98	1.46	1.55	0.52
postcentral gyrus, adult, pool1	10032-101E5	13.77	5.49	10.03	8.02	1.31	4.62	1.13	0.00	0.52	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	192.41	20.91	4.18	2.09	14.64	10.46	6.27	6.27	8.37	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	14.42	1.75	2.18	0.58	1.17	0.73	0.15	0.44	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	57.35	5.63	6.17	3.27	4.36	4.36	1.82	0.54	1.63	0.18
prostate, adult, pool1	10022-101D4	36.46	4.63	6.35	3.90	2.99	2.81	1.45	0.63	1.09	0.09
putamen, adult, donor10196	10176-103C5	21.72	5.90	11.33	20.07	1.89	8.26	0.71	0.47	0.94	0.24
putamen, adult, donor10252	10152-102I8	33.33	11.76	3.92	11.76	3.92	3.92	0.00	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	3.28	1.09	3.28	6.56	3.28	2.19	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.53	6.28	6.52	12.08	3.14	4.11	0.72	0.48	0.48	0.24
putamen, newborn, donor10223	10365-105F5	9.75	3.75	0.75	3.75	3.00	0.00	0.00	0.75	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	219.66	21.24	9.02	6.11	21.82	12.80	24.44	4.65	8.44	25.02
rectum, fetal, donor1	10067-101I4	121.02	4.17	6.95	4.17	1.39	2.78	4.17	0.00	0.00	9.74
renal cell carcinoma cell line:OS-RC-2	10411-106B6	7.42	0.21	1.06	1.70	0.42	1.48	0.00	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.81	1.24	2.49	3.31	0.00	0.41	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	62.42	16.70	12.92	7.16	6.46	7.36	3.28	1.49	1.99	1.69
retinoblastoma cell line:Y79	10475-106I7	7.27	1.04	5.46	4.68	0.78	3.12	0.52	0.00	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.85	3.93	2.70	2.95	7.62	4.43	10.57	2.70	1.11	7.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	63.27	4.78	4.50	5.91	1.12	5.91	2.81	0.00	1.12	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.96	6.06	3.03	2.27	9.09	1.52	6.06	2.27	2.27	3.79
salivary acinar cells, donor1	11771-123I7	14.24	0.97	2.10	0.49	2.27	1.62	0.16	1.13	0.49	0.00
salivary acinar cells, donor2	11772-123I8	21.75	2.62	1.79	1.38	3.30	0.55	0.55	0.55	0.00	0.69
salivary acinar cells, donor3	11773-123I9	86.07	1.99	3.31	0.66	5.96	1.32	2.65	5.30	1.32	3.31
salivary gland, adult, pool1	10093-102C3	33.17	6.86	5.15	4.58	60.05	2.86	2.29	5.72	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.55	14.59	8.94	3.12	2.53	2.36	0.84	0.59	2.53	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.67	9.76	7.64	3.17	2.12	3.06	0.94	0.71	1.06	0.82
seminal vesicle, adult	10201-103F3	24.34	3.17	3.17	3.70	1.06	2.65	0.53	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	52.47	14.09	5.34	3.64	20.41	5.10	7.04	7.53	1.21	3.16
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.55	4.03	3.77	2.52	1.26	1.76	0.00	1.01	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	3.01	3.01	2.01	0.00	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.39	5.24	2.55	1.75	1.61	3.76	0.81	0.54	1.88	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	34.37	5.97	2.32	1.77	3.32	1.44	0.33	0.66	0.44	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	65.16	9.16	2.84	2.19	21.55	2.58	4.64	6.97	1.16	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	39.72	2.84	4.26	8.51	5.67	4.97	1.42	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	26.39	2.76	4.56	3.48	1.68	3.12	0.36	0.12	0.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	5.03	0.00	1.01	5.03	0.00	3.02	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	135.70	0.00	0.00	0.00	6.79	6.79	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	49.87	5.68	4.42	6.94	6.31	3.16	4.42	4.42	0.63	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.68	4.34	8.34	7.34	0.33	3.00	1.33	1.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.81	8.20	5.04	2.21	1.26	3.15	0.32	0.95	1.26	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.85	0.77	1.16	1.54	0.19	1.93	0.39	0.39	0.19	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	18.63	1.65	2.14	1.98	1.48	1.81	0.16	0.16	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	7.24	1.93	6.59	9.01	0.80	6.92	0.00	0.16	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	11.11	2.62	2.62	2.83	1.96	2.62	0.22	0.44	1.74	0.00
small intestine, adult, pool1	10024-101D6	76.32	6.81	5.49	1.91	6.45	2.87	2.27	0.84	1.67	0.72
small intestine, fetal, donor1	10064-101I1	23.10	7.13	4.67	5.41	1.23	4.18	2.21	0.49	0.98	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.57	8.21	3.59	4.10	2.56	5.13	1.54	3.08	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	23.26	3.62	6.46	4.65	0.78	5.17	0.78	0.26	0.52	0.78
somatostatinoma cell line:QGP-1	10781-110G7	32.16	1.34	2.41	1.88	2.95	1.88	1.88	1.61	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	55.98	15.60	11.24	14.45	3.21	10.32	1.84	1.84	0.92	0.46
spinal cord, adult, donor10252	10159-103A6	71.36	27.60	25.23	12.62	8.28	18.53	3.15	0.39	1.97	0.00
spinal cord, adult, donor10258	10369-105F9	8.99	10.38	5.53	13.84	11.07	3.46	2.08	1.38	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	40.25	6.10	5.49	6.71	3.66	6.10	5.49	4.88	0.00	3.66
spinal cord, newborn, donor10223	10359-105E8	13.78	6.43	5.05	1.84	3.67	4.13	1.38	2.30	2.30	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.90	4.48	2.84	2.39	3.29	2.39	1.49	1.05	0.00	0.15
spleen, adult, pool1	10025-101D7	39.87	4.52	5.62	4.30	1.43	3.52	0.99	0.66	0.77	0.44
spleen, fetal, pool1	10044-101F8	43.30	6.59	5.88	3.02	1.43	4.45	2.22	0.64	0.48	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.70	0.72	1.55	1.45	0.21	1.55	0.00	0.41	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.35	2.66	4.18	2.47	1.71	1.52	0.38	0.38	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	14.68	2.45	1.75	0.70	1.40	1.40	0.70	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	10.16	5.08	2.74	7.04	3.91	2.74	3.13	2.35	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.71	5.97	4.95	4.05	1.91	4.39	0.00	0.34	0.45	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.03	3.81	5.51	1.69	0.00	4.24	0.85	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	69.38	3.81	4.65	0.00	2.12	2.12	1.69	0.85	0.42	1.27
stomach, fetal, donor1	10062-101H8	131.36	9.61	3.20	9.61	1.07	3.20	7.48	2.14	1.07	3.20
submaxillary gland, adult	10202-103F4	59.25	10.25	2.28	3.99	42.73	2.85	0.57	5.70	1.14	2.28
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	54.27	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	63.14	31.16	19.73	13.71	12.25	17.45	2.49	2.08	2.91	1.04
substantia nigra, adult, donor10258	10371-105G2	9.31	6.21	5.69	13.97	12.93	7.76	2.59	0.52	1.55	2.59
substantia nigra, newborn, donor10223	10358-105E7	26.14	6.36	4.95	6.36	4.24	0.00	1.41	2.12	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.25	0.92	2.06	4.59	0.92	2.29	0.46	0.23	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	14.24	4.15	5.93	6.44	0.85	3.81	0.59	0.00	0.59	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.26	2.14	2.14	8.55	0.00	3.56	0.00	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	6.59	0.88	2.20	3.96	0.00	1.76	0.00	0.00	0.00	1.32
tenocyte, donor1	11763-123H8	7.68	0.35	1.75	1.40	1.05	0.35	0.35	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	9.16	2.67	1.91	3.05	0.00	1.91	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	9.27	1.11	0.37	0.74	0.00	0.74	0.00	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.52	0.68	0.17	1.36	0.34	0.34	0.00	0.00	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	11.10	2.00	2.62	3.39	0.77	3.39	1.23	0.15	0.46	0.77
teratocarcinoma cell line:PA-1	10807-111A6	7.44	1.08	0.62	2.01	0.15	1.24	0.31	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	4.57	0.13	0.38	0.38	0.38	0.51	0.25	0.13	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.86	0.38	0.76	1.51	0.00	0.38	0.38	0.00	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.80	0.11	0.22	0.44	1.64	0.22	0.65	0.22	0.44	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	0.65	0.98	0.98	0.65	0.00	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	37.90	8.38	8.38	15.25	3.22	6.44	2.36	1.40	1.50	0.75
testis, adult, pool2	10096-102C6	36.09	5.86	7.67	22.10	2.26	9.02	0.90	2.26	1.35	0.45
thalamus - adult, donor10196	10168-103B6	30.91	6.62	11.04	4.42	6.62	3.31	1.10	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	59.39	25.63	17.35	11.88	6.10	11.10	2.03	0.78	1.56	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	12.32	3.08	21.55	15.40	3.08	0.00	0.00	3.08	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.94	6.59	4.45	12.35	1.65	5.76	1.48	0.33	0.82	0.16
thalamus, newborn, donor10223	10366-105F6	4.60	0.58	2.30	1.73	1.73	2.30	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	24.22	3.99	3.50	3.00	4.24	2.50	1.00	1.50	0.75	0.75
throat, fetal, donor1	10061-101H7	38.70	3.05	6.40	6.40	1.52	7.62	2.44	0.91	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	2.78	0.20	1.19	1.19	0.00	0.40	0.20	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	8.15	2.78	13.62	7.95	0.89	10.24	0.40	0.40	0.10	0.40
thymus, fetal, pool1	10043-101F7	19.33	4.57	19.64	12.57	1.87	13.51	0.94	0.31	1.04	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.18	2.26	0.80	0.40	1.20	0.93	0.80	0.27	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	35.48	5.59	5.03	4.19	4.19	3.21	0.70	0.84	0.98	0.56
thyroid, adult, pool1	10028-101E1	53.93	6.25	6.81	5.23	4.20	2.80	0.65	0.37	2.15	0.19
thyroid, fetal, donor1	10060-101H6	43.50	4.22	7.38	3.43	3.16	2.90	2.90	0.79	0.00	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	9.24	9.24	9.24	18.48	3.08	0.00	12.32	3.08	3.08
tongue, adult	10203-103F5	18.84	2.79	3.72	4.88	7.68	4.88	0.93	1.16	0.93	0.70
tongue, fetal, donor1	10059-101H5	31.13	2.76	6.31	3.55	3.15	4.34	1.18	1.58	0.39	0.39
tonsil, adult, pool1	10047-101G2	22.04	2.70	4.41	2.60	2.30	2.70	0.70	0.70	0.50	0.20
trachea, adult, pool1	10029-101E2	45.97	5.24	4.34	3.11	9.41	2.54	0.82	1.96	2.13	0.00
trachea, fetal, donor1	10058-101H4	31.93	3.46	5.00	6.16	6.16	4.23	1.54	0.77	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	69.79	8.86	4.25	6.38	12.40	4.61	5.31	3.90	1.77	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	40.02	6.99	2.94	3.04	8.41	1.82	2.03	1.32	1.62	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	30.08	2.98	2.35	2.04	1.72	1.10	0.16	0.00	0.16	0.31
tridermal teratoma cell line:HGRT	10694-109G1	133.18	13.32	3.81	3.81	1.90	3.81	13.32	1.90	3.81	13.32
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	142.38	11.51	2.88	4.74	23.96	4.40	41.14	12.78	4.15	22.43
umbilical cord, fetal, donor1	10057-101H3	14.61	0.00	8.35	0.00	0.00	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	30.71	5.97	6.14	3.24	3.58	5.80	5.12	1.54	1.54	1.37
uterus, fetal, donor1	10055-101H1	38.39	2.05	5.63	4.61	2.56	1.02	2.05	2.05	0.51	0.51
vagina, adult	10204-103F6	54.28	9.69	5.17	9.05	3.23	5.82	0.65	0.00	1.29	0.00
vein, adult	10191-103E2	20.82	2.85	5.04	2.63	1.75	3.95	0.66	1.32	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	3.20	0.00	0.53	1.07	0.00	0.80	0.00	0.00	0.00	0.00